query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7udq-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7udq-assembly1.cif.gz_A Crystal structure of COQ8A-CA157 inhibitor complex in space group P1	0.200	381	289	50	430	6	367	1.135E-16	586
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7udq-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7udq-assembly2.cif.gz_B Crystal structure of COQ8A-CA157 inhibitor complex in space group P1	0.218	381	294	49	429	1	377	2.700E-17	586
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5i35-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5i35-assembly1.cif.gz_A Structure of the Human mitochondrial kinase COQ8A R611K with AMPPNP (Cerebellar Ataxia and Ubiquinone Deficiency Through Loss of Unorthodox Kinase Activity)	0.226	380	290	54	429	4	383	1.687E-16	565
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7udp-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7udp-assembly1.cif.gz_A Crystal structure of COQ8A-CA157 inhibitor complex in space group C2	0.213	381	296	49	429	1	377	1.135E-16	555
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ped-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ped-assembly1.cif.gz_A Mitochondrial ADCK3 employs an atypical protein kinase-like fold to enable coenzyme Q biosynthes	0.213	386	299	49	429	1	386	2.161E-16	543
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7cz2-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7cz2-assembly1.cif.gz_A The complex structure of MSMEG_1954-ADP from Mycobacterium smegmatis	0.244	328	233	96	423	1	309	3.821E-15	536
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7cyr-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7cyr-assembly1.cif.gz_A The closed conformation of MSMEG_1954 from Mycobacterium smegmatis	0.252	377	275	51	419	9	385	6.919E-17	533
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7cy2-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7cy2-assembly1.cif.gz_A The open conformation of MSMEG_1954 from Mycobacterium smegmatis	0.241	326	235	94	419	1	310	1.254E-14	499
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5yk1-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5yk1-assembly1.cif.gz_A The complex structure of Rv3197-AMPPNP from Mycobacterium tuberculosis	0.251	361	264	57	409	20	380	2.162E-14	432
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5yk2-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5yk2-assembly1.cif.gz_A The complex structure of Rv3197-erythromycin from Mycobacterium tuberculosis	0.246	353	265	57	409	20	371	6.428E-14	421
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4px6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4px6-assembly1.cif.gz_A SYK catalytic domain in complex with a potent pyridopyrimidinone inhibitor	0.148	287	214	112	398	1	252	1.777E-06	156
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6b2q-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6b2q-assembly2.cif.gz_B Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.163	276	215	114	389	7	264	2.276E-06	154
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7vbt-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7vbt-assembly1.cif.gz_B Crystal structure of RIOK2 in complex with CQ211	0.128	338	241	48	385	7	283	4.124E-06	153
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fdn-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fdn-assembly1.cif.gz_A Rio2 structure	0.149	264	171	80	343	23	224	2.114E-05	149
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fdm-assembly2.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fdm-assembly2.cif.gz_C Human Rio2 kinase structure	0.129	340	244	48	387	5	285	2.916E-06	149
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1o6y-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1o6y-assembly1.cif.gz_A Catalytic domain of PknB kinase from Mycobacterium tuberculosis	0.153	285	210	116	400	7	255	3.064E-06	146
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5lmb-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5lmb-assembly2.cif.gz_B HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR	0.153	284	215	115	398	4	258	4.553E-06	145
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7up7-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7up7-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound with literature RSK2 inhibitor indazole cyanoacrylamide compound 26 (soak)	0.152	314	235	112	425	2	279	3.064E-06	143
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fdo-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fdo-assembly2.cif.gz_B Rio2 structure	0.129	340	245	48	387	3	284	7.850E-06	143
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5u94-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5u94-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PASTA kinase PknB in complex with the potential theraputic kinase inhibitor GSK690693.	0.167	289	212	112	400	3	258	5.550E-06	140
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yju-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yju-assembly1.cif.gz_A THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000249	0.139	287	223	112	398	1	260	5.550E-06	140
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hm7-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hm7-assembly1.cif.gz_A CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A 2-(PHENOXYMETHYL)PYRIDINE INHIBITOR	0.154	284	217	115	398	5	261	7.850E-06	140
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fdm-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fdm-assembly1.cif.gz_B Human Rio2 kinase structure	0.125	296	221	48	343	1	253	1.006E-05	140
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3lm0-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3lm0-assembly1.cif.gz_A Crystal Structure of human Serine/Threonine Kinase 17B (STK17B)	0.138	306	216	115	420	12	263	5.832E-06	139
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2y7j-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2y7j-assembly1.cif.gz_B Structure of human phosphorylase kinase, gamma 2	0.151	286	229	115	400	9	279	4.553E-06	138
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2y7j-assembly1.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2y7j-assembly1.cif.gz_C Structure of human phosphorylase kinase, gamma 2	0.158	286	230	115	400	9	282	5.550E-06	137
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7q7d-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7q7d-assembly1.cif.gz_A Room temperature structure of the human Serine/Threonine Kinase 17B (STK17B/DRAK2) in complex with ATP/ADP at 111 MPa helium gas pressure in a sapphire capillary	0.143	300	228	115	414	12	278	7.850E-06	136
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg6-assembly1.cif.gz_A Crystal structure of an inhibitor-bound Syk	0.130	313	230	115	427	5	269	5.027E-06	135
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hm6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hm6-assembly1.cif.gz_A CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A 2-(PYRIDINYLOXYMETHYL)PYRIDINE INHIBITOR	0.116	313	229	112	424	1	260	1.110E-05	134
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg3-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg3-assembly2.cif.gz_B Crystal structure of an inhibitor-bound Syk	0.127	315	228	115	429	5	266	8.248E-06	134
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ghv-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ghv-assembly2.cif.gz_B Crystal structure of an inhibitor-bound Syk	0.137	313	224	115	427	5	264	9.570E-06	133
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg9-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg9-assembly2.cif.gz_B Crystal structure of an inhibitor-bound Syk	0.132	307	221	120	426	9	264	5.832E-06	133
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4rx8-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4rx8-assembly1.cif.gz_A SYK Catalytic Domain Complexed with a Potent Triazine Inhibitor2	0.153	287	217	112	398	1	257	8.667E-06	133
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yjt-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yjt-assembly1.cif.gz_A THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000233	0.141	287	225	112	398	1	263	1.288E-05	133
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3lm5-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3lm5-assembly1.cif.gz_A Crystal Structure of human Serine/Threonine Kinase 17B (STK17B) in complex with Quercetin	0.134	306	217	115	420	12	262	6.766E-06	133
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6eir-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6eir-assembly2.cif.gz_B DYRK1A in complex with XMD15-27-2	0.137	283	207	95	377	1	241	5.027E-06	133
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yjp-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yjp-assembly1.cif.gz_A THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000223	0.143	287	219	112	398	1	257	1.734E-05	132
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7q7c-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7q7c-assembly1.cif.gz_A Room temperature structure of the human Serine/Threonine Kinase 17B (STK17B/DRAK2) in complex with ADP at atmospheric pressure	0.147	300	220	115	414	12	270	1.650E-05	132
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6aaj-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6aaj-assembly2.cif.gz_B Crystal structure of JAK2 in complex with peficitinib	0.133	303	227	124	426	11	273	1.226E-05	132
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8g8o-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8g8o-assembly1.cif.gz_B The crystal structure of JAK2 in complex with Compound 31	0.125	311	240	115	425	4	278	1.650E-05	132
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3emg-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3emg-assembly1.cif.gz_A Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)	0.157	279	205	120	398	7	250	2.221E-05	131
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg9-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg9-assembly1.cif.gz_A Crystal structure of an inhibitor-bound Syk	0.149	284	211	115	398	5	253	1.167E-05	131
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4rx7-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4rx7-assembly1.cif.gz_A SYK Catalytic Domain Complexed with a Potent Triazine Inhibitor	0.134	310	227	120	429	9	271	7.850E-06	131
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2y7j-assembly1.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2y7j-assembly1.cif.gz_D Structure of human phosphorylase kinase, gamma 2	0.180	242	186	115	356	9	236	1.288E-05	131
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hk6-assembly3.cif.gz_E	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hk6-assembly3.cif.gz_E Human RIOK2 bound to inhibitor	0.138	296	223	48	343	11	270	1.822E-05	131
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7vbt-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7vbt-assembly1.cif.gz_A Crystal structure of RIOK2 in complex with CQ211	0.139	338	243	48	385	9	291	1.822E-05	131
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vov-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vov-assembly2.cif.gz_B Crystal structure of Syk in complex with GS-9876	0.151	284	215	115	398	4	257	2.577E-05	130
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4i0t-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4i0t-assembly1.cif.gz_A Crystal structure of spleen tyrosine kinase complexed with 2-(5,6,7,8-Tetrahydro-imidazo[1,5-a]pyridin-1-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid tert-butylamide	0.122	315	227	115	429	5	263	2.707E-05	130
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5y5u-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5y5u-assembly1.cif.gz_A Crystal structures of spleen tyrosine kinase in complex with a novel inhibitor	0.113	314	233	112	425	1	264	1.353E-05	130
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6wtp-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6wtp-assembly1.cif.gz_A Human JAK2 JH1 domain in complex with PROTAC-intermediate linker handle 3	0.130	310	238	118	427	1	274	6.766E-06	129
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4e6d-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4e6d-assembly2.cif.gz_B JAK2 kinase (JH1 domain) triple mutant in complex with compound 7	0.130	304	238	124	427	14	287	2.334E-05	129
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7oai-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7oai-assembly1.cif.gz_A Crystal structure of pseudokinase CASK in complex with PFE-PKIS12	0.146	290	243	112	397	2	291	1.650E-05	129
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vf8-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vf8-assembly1.cif.gz_A Crystal Structure of Spleen Tyrosine Kinase Syk Catalytic Domain with Pyrazolylbenzimidazole Inhibitor 416	0.131	313	225	115	427	5	264	1.110E-05	128
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5cy3-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5cy3-assembly1.cif.gz_A SYK catalytic domain complexed with a potent and orally bioavailable benzisothiazole inhibitor	0.156	279	214	120	398	12	265	1.734E-05	128
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5y5u-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5y5u-assembly2.cif.gz_B Crystal structures of spleen tyrosine kinase in complex with a novel inhibitor	0.146	311	214	115	425	5	256	2.989E-05	127
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vov-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vov-assembly1.cif.gz_A Crystal structure of Syk in complex with GS-9876	0.123	311	221	115	425	5	257	2.577E-05	127
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5usy-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5usy-assembly2.cif.gz_B JAK2 JH1 in complex with JNJ-7706621	0.126	302	239	124	425	14	287	1.057E-05	127
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5tr6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5tr6-assembly1.cif.gz_A Discovery of TAK-659, an Orally Available Investigational Inhibitor of Spleen Tyrosine Kinase (SYK)	0.125	316	231	115	430	6	270	4.668E-05	126
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5cf4-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5cf4-assembly1.cif.gz_A CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL-10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-3,5,8,10-TETRAAZATRICYCLO[7.3.0.0,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11-CARBOXAMIDE	0.135	303	236	124	426	11	284	1.288E-05	126
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hez-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hez-assembly2.cif.gz_B JAK2 kinase (JH1 domain) mutant P1057A in complex with TG101209	0.126	304	243	124	427	12	290	1.422E-05	126
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8x5k-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8x5k-assembly1.cif.gz_A The Crystal Structure of SYK from Biortus.	0.126	310	225	115	424	5	263	2.707E-05	125
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vf9-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vf9-assembly1.cif.gz_A Crystal Structure of Spleen Tyrosine Kinase Syk Catalytic Domain with Thienopyrazolylindole Inhibitor 027	0.131	308	222	120	427	8	264	2.577E-05	125
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6zcp-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6zcp-assembly1.cif.gz_A SYK Kinase domain in complex with azabenzimidazole inhibitor 2b	0.118	316	230	115	430	5	266	2.707E-05	125
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2j5f-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2j5f-assembly1.cif.gz_A Crystal structure of EGFR kinase domain in complex with an irreversible inhibitor 34-jab	0.125	293	228	115	407	14	274	7.110E-06	125
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4rx9-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4rx9-assembly1.cif.gz_A SYK Catalytic Domain Complexed with a Potent Pyrimidine Inhibitor	0.124	316	229	115	430	5	266	1.914E-05	124
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4d1s-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4d1s-assembly1.cif.gz_A Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors	0.141	294	225	132	425	19	281	1.110E-05	124
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2qoc-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2qoc-assembly1.cif.gz_A Human EphA3 kinase domain, phosphorylated, AMP-PNP bound structure	0.137	308	218	120	427	10	263	6.439E-06	124
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3d7u-assembly2.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3d7u-assembly2.cif.gz_C Structural basis for the recognition of c-Src by its inactivator Csk	0.129	287	213	112	398	3	247	2.334E-05	123
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6tpd-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6tpd-assembly1.cif.gz_A Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity	0.120	302	243	124	425	12	288	2.707E-05	123
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6x8g-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6x8g-assembly1.cif.gz_A Crystal structure of TYK2 with Compound 22	0.112	304	238	124	427	13	281	1.914E-05	122
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8bi2-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8bi2-assembly1.cif.gz_A Syk kinase domain in complex with macrocyclic inhibitor 20a	0.130	315	226	115	429	5	265	7.660E-05	121
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5cxh-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5cxh-assembly1.cif.gz_A SYK catalytic domain complexed with a potent orally bioavailable thiazole inhibitor	0.151	279	216	120	398	9	264	1.734E-05	121
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8g6z-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8g6z-assembly1.cif.gz_B JAK2 crystal structure in complex with Compound 13	0.122	303	235	124	426	11	279	5.416E-05	121
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yti-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yti-assembly1.cif.gz_A Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Disease	0.131	302	237	124	425	12	285	3.468E-05	121
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6qf4-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6qf4-assembly1.cif.gz_A X-Ray structure of human Serine/Threonine Kinase 17B (STK17B) aka DRAK2 in complex with ADP obtained by on-chip soaking	0.132	276	192	115	390	12	233	1.288E-05	121
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5l3a-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5l3a-assembly1.cif.gz_A Fragment-based discovery of 6-arylindazole JAK inhibitors	0.128	302	241	124	425	13	289	2.577E-05	121
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg4-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg4-assembly1.cif.gz_A Crystal structure of an inhibitor-bound Syk	0.136	308	219	120	427	9	263	8.667E-06	120
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fz6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fz6-assembly1.cif.gz_A Crystal structure of spleen tyrosine kinase complexed with [6-((S)-2-Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-imidazo[1,2-b]pyridazin-8-yl)-amine	0.145	284	212	115	398	5	253	3.468E-05	120
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fyn-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fyn-assembly1.cif.gz_A Crystal structure of spleen tyrosine kinase complexed with 3-(8-{4-[Ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,2-a]pyrazin-5-yl)-phenol	0.143	314	221	116	429	6	264	1.822E-05	120
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5y5t-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5y5t-assembly1.cif.gz_A Crystal structures of spleen tyrosine kinase in complex with a novel inhibitor	0.132	313	223	115	427	5	262	2.334E-05	119
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fz7-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fz7-assembly1.cif.gz_A Crystal structure of spleen tyrosine kinase complexed with 6-((1R,2S)-2-Amino-cyclohexylamino)-4-(6-ethyl-pyridin-2-ylamino)-pyridazine-3-carboxylic acid amide	0.119	315	226	115	429	5	262	2.334E-05	119
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7quf-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7quf-assembly1.cif.gz_A The STK17A (DRAK1) Kinase Domain Bound to CK156	0.144	289	225	112	400	6	269	1.321E-04	119
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5tq6-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5tq6-assembly2.cif.gz_B Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin	0.136	281	226	124	404	11	272	5.416E-05	119
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uyw-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uyw-assembly1.cif.gz_A Crystal structure of JAK2 kinase domain in complex with compound 30	0.128	303	242	124	426	12	289	2.011E-05	119
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4i0s-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4i0s-assembly1.cif.gz_A Crystal structure of spleen tyrosine kinase complexed with 2-(6-Chloro-1-methyl-1H-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid isopropylamide	0.134	315	224	115	429	5	264	7.290E-05	118
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6zcq-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6zcq-assembly1.cif.gz_A SYK Kinase domain in complex with diamine inhibitor 5	0.144	284	215	115	398	5	256	6.937E-05	118
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2xa4-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2xa4-assembly2.cif.gz_B Inhibitors of Jak2 Kinase domain	0.120	303	233	124	426	11	276	4.442E-05	118
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ueu-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ueu-assembly1.cif.gz_A Tyrosine kinase AS - a common ancestor of Src and Abl	0.122	287	216	112	398	6	252	1.778E-04	117
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5vja-assembly1.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5vja-assembly1.cif.gz_D Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.154	313	219	112	424	1	260	3.301E-05	117
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4f4p-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4f4p-assembly1.cif.gz_A SYK in COMPLEX WITH LIGAND LASW836	0.131	308	219	120	427	7	259	1.914E-05	117
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4dfl-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4dfl-assembly1.cif.gz_A Crystal structure of spleen tyrosine kinase complexed with a sulfonamidopyrazine piperidine inhibitor	0.145	284	212	115	398	5	253	1.138E-04	117
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3g6h-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3g6h-assembly1.cif.gz_A Src Thr338Ile inhibited in the DFG-Asp-Out conformation	0.154	284	204	112	395	5	246	1.321E-04	117
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7que-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7que-assembly1.cif.gz_A The STK17A (DRAK1) Kinase Domain Bound to CKJB68	0.138	289	223	112	400	6	265	1.458E-04	117
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1k9a-assembly6.cif.gz_F	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1k9a-assembly6.cif.gz_F Crystal structure analysis of full-length carboxyl-terminal Src kinase at 2.5 A resolution	0.122	319	218	112	430	185	433	4.784E-06	117
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fdn-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fdn-assembly1.cif.gz_B Rio2 structure	0.139	295	208	48	342	1	243	9.812E-05	116
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4p2k-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4p2k-assembly1.cif.gz_A Structure of Ephrin type-A receptor 2	0.134	310	218	91	400	6	258	5.691E-05	116
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zmm-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zmm-assembly2.cif.gz_B Inhibitors of Jak2 Kinase domain	0.130	303	230	124	426	11	275	5.416E-05	116
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4e20-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4e20-assembly1.cif.gz_A Structure of mouse Tyk-2 complexed to a 3-aminoindazole inhibitor	0.116	309	237	124	432	14	282	5.691E-05	116
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8c12-assembly1.cif.gz_AAA	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8c12-assembly1.cif.gz_AAA Identification of an intermediate activation state of PAK5 reveals a novel mechanism of kinase inhibition.	0.162	319	241	95	413	1	289	2.845E-05	116
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg8-assembly2.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg8-assembly2.cif.gz_C Crystal structure of an inhibitor-bound Syk	0.123	311	218	115	425	4	253	8.887E-05	115
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3orm-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3orm-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain D76A mutant	0.169	271	215	120	390	1	260	2.334E-05	115
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4rss-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4rss-assembly1.cif.gz_A Crystal structure of tyrosine-protein kinase SYK with an inhibitor	0.134	279	219	120	398	8	261	2.707E-05	115
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8g8x-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8g8x-assembly1.cif.gz_A X-ray co-crystal structure of compound 27 in with complex JAK2	0.127	302	232	124	425	12	278	7.660E-05	115
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8g6z-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8g6z-assembly1.cif.gz_A JAK2 crystal structure in complex with Compound 13	0.119	303	237	124	426	11	280	6.937E-05	115
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3kck-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3kck-assembly1.cif.gz_A A Novel Chemotype of Kinase Inhibitors	0.134	293	231	133	425	19	286	3.141E-05	115
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vny-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vny-assembly1.cif.gz_A Crystal structure of TYK2 kinase with compound 10	0.108	306	242	124	429	13	284	4.024E-05	115
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hez-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hez-assembly1.cif.gz_A JAK2 kinase (JH1 domain) mutant P1057A in complex with TG101209	0.130	304	240	124	427	12	288	6.283E-05	115
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4jdk-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4jdk-assembly1.cif.gz_A Crystal structure of Serine/threonine-protein kinase PAK 4 F461V mutant in complex with Paktide S peptide substrate	0.159	329	238	85	413	3	286	4.024E-05	115
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4c0t-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4c0t-assembly1.cif.gz_A Candida albicans PKh Kinase Domain	0.135	305	236	112	416	3	276	8.887E-05	115
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vnf-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vnf-assembly1.cif.gz_B JAK2 JH1 in complex with MA9-086	0.132	303	240	124	426	13	290	5.980E-05	115
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3fqh-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3fqh-assembly2.cif.gz_B Crystal structure of spleen tyrosine kinase complexed with a 2-substituted 7-azaindole	0.139	306	214	120	425	9	257	2.011E-05	114
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3dqw-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3dqw-assembly3.cif.gz_C c-Src kinase domain Thr338Ile mutant in complex with ATPgS	0.146	284	214	112	395	5	256	2.393E-04	114
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ggh-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ggh-assembly2.cif.gz_B Human jak1 kinase domain in complex with inhibitor	0.098	300	238	124	423	17	281	5.691E-05	114
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6aaj-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6aaj-assembly1.cif.gz_A Crystal structure of JAK2 in complex with peficitinib	0.138	302	234	124	425	11	282	2.845E-05	114
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3eyh-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3eyh-assembly1.cif.gz_A Crystal structures of JAK1 and JAK2 inhibitor complexes	0.119	303	238	124	426	15	285	8.457E-05	114
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4gvj-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4gvj-assembly1.cif.gz_A Tyk2 (JH1) in complex with adenosine di-phosphate	0.112	302	243	124	425	13	287	5.980E-05	114
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5wvd-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5wvd-assembly1.cif.gz_A Structure of Mnk1 in complex with DS12881479	0.120	276	210	112	387	2	241	4.125E-04	113
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2in6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2in6-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD311839	0.154	309	211	112	420	3	252	2.167E-04	113
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg8-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg8-assembly1.cif.gz_A Crystal structure of an inhibitor-bound Syk	0.150	284	210	115	398	2	249	1.031E-04	113
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4d55-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4d55-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain	0.127	313	220	115	427	7	259	8.887E-05	113
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2dq7-assembly1.cif.gz_X	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2dq7-assembly1.cif.gz_X Crystal Structure of Fyn kinase domain complexed with staurosporine	0.158	284	211	112	395	6	257	2.642E-04	113
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3srv-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3srv-assembly1.cif.gz_A Crystal structure of spleen tyrosine kinase (SYK) in complex with a diaminopyrimidine carboxamide inhibitor	0.147	279	211	120	398	8	255	6.937E-05	113
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5xp7-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5xp7-assembly1.cif.gz_A C-Src in complex with ATP-CHCl	0.149	284	203	112	395	6	245	1.610E-04	113
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8g8x-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8g8x-assembly1.cif.gz_B X-ray co-crystal structure of compound 27 in with complex JAK2	0.119	302	238	124	425	12	282	5.154E-05	113
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg7-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg7-assembly1.cif.gz_A Crystal structure of an inhibitor-bound Syk	0.137	287	220	112	398	1	256	4.905E-05	112
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5lma-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5lma-assembly1.cif.gz_A HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR	0.161	284	216	115	398	5	262	8.049E-05	112
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5cxz-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5cxz-assembly1.cif.gz_A SYK catalytic domain complexed with naphthyridine inhibitor	0.131	308	223	120	427	9	266	6.602E-05	112
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vnv-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vnv-assembly1.cif.gz_A Crystal structure of TYK2 kinase with compound 14	0.110	304	232	124	427	13	274	4.442E-05	112
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4gl9-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4gl9-assembly4.cif.gz_D Crystal structure of inhibitory protein SOCS3 in complex with JAK2 kinase domain and fragment of GP130 intracellular domain	0.126	302	238	124	425	11	283	8.049E-05	112
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6z1c-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6z1c-assembly1.cif.gz_A Crystal structure of Arabidopsis thaliana CK2-alpha-1 in complex with TTP-22	0.111	344	292	91	434	2	330	1.650E-05	112
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4v0g-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4v0g-assembly2.cif.gz_B JAK3 in complex with a covalent EGFR inhibitor	0.148	276	199	115	390	4	238	1.778E-04	111
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uyt-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uyt-assembly1.cif.gz_A Crystal structure of TYK2 kinase domain in complex with compound 25	0.113	301	233	124	424	12	275	6.602E-05	111
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6x8e-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6x8e-assembly2.cif.gz_B Crystal structure of JAK2 with Compound 11	0.138	302	230	124	425	11	278	1.083E-04	111
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4p7e-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4p7e-assembly1.cif.gz_A Triazolopyridine compounds as selective JAK1 inhibitors: from hit identification to GLPG0634	0.121	304	238	124	427	11	282	1.083E-04	111
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ytc-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ytc-assembly1.cif.gz_A Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Disease	0.137	293	230	133	425	19	285	5.416E-05	111
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3fxx-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3fxx-assembly1.cif.gz_A Human EphA3 Kinase and Juxtamembrane Region Bound to Substrate KQWDNYE[pTyr]IW	0.128	275	237	114	388	4	276	2.011E-05	111
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qny-assembly3.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qny-assembly3.cif.gz_B Crystal structure of MapK from Leishmania donovani, LDBPK_331470	0.151	301	239	120	420	19	301	2.989E-05	111
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7cga-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7cga-assembly3.cif.gz_C Crystal structure of human unphosphorylated p38gamma	0.155	328	267	112	428	17	344	1.494E-05	111
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5w86-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5w86-assembly4.cif.gz_D CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)	0.131	277	201	114	390	6	237	2.642E-04	110
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4agu-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4agu-assembly3.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.151	302	228	119	420	1	270	8.887E-05	110
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7lgs-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7lgs-assembly2.cif.gz_B Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	0.098	305	239	121	425	11	276	1.083E-04	110
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2hw6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2hw6-assembly1.cif.gz_A Crystal structure of Mnk1 catalytic domain	0.135	276	205	112	387	4	241	6.131E-04	109
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yjv-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yjv-assembly1.cif.gz_A THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000250	0.137	287	222	112	398	1	258	7.290E-05	109
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7lgs-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7lgs-assembly4.cif.gz_D Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	0.115	287	230	121	407	12	272	8.457E-05	109
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uys-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uys-assembly1.cif.gz_A Crystal structure of TYK2 kinase domain in complex with compound 16	0.120	295	230	131	425	19	280	3.829E-05	109
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2cn5-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2cn5-assembly1.cif.gz_A-2 Crystal structure of human Chk2 in complex with ADP	0.137	319	236	114	432	9	283	7.660E-05	109
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7lgs-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7lgs-assembly1.cif.gz_A Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	0.100	305	236	121	425	11	273	7.290E-05	109
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3fy2-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3fy2-assembly1.cif.gz_A Human EphA3 Kinase and Juxtamembrane Region Bound to Substrate KQWDNYEFIW	0.130	314	232	114	427	3	270	2.114E-05	109
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6drw-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6drw-assembly1.cif.gz_A JAK2 JH1 in complex with JNJ-7706621 (Crystal Form 2)	0.120	293	232	133	425	24	288	4.668E-05	109
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vnx-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vnx-assembly1.cif.gz_A Crystal structure of TYK2 kinase with compound 19	0.124	304	242	124	427	13	289	8.887E-05	109
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vnk-assembly4.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vnk-assembly4.cif.gz_A JAK2 JH1 in complex with PN4-073	0.131	304	241	124	427	19	296	1.196E-04	109
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg3-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg3-assembly1.cif.gz_A Crystal structure of an inhibitor-bound Syk	0.115	312	227	115	426	5	261	4.442E-05	108
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6cd6-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6cd6-assembly3.cif.gz_C Crystal Structure of the Human CAMKK1A in complex with GSK650394	0.163	189	126	120	308	6	156	7.113E-04	108
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5tq6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5tq6-assembly1.cif.gz_A Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin	0.130	303	229	124	426	11	274	1.321E-04	108
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6sm8-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6sm8-assembly2.cif.gz_B Human jak1 kinase domain in complex with inhibitor	0.104	300	240	124	423	15	283	4.905E-05	108
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6l24-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6l24-assembly1.cif.gz_A Crystal structure of CK2a1 H115Y/V116I with hematein	0.124	324	270	110	433	25	333	5.691E-05	108
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1mqb-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1mqb-assembly2.cif.gz_B Crystal Structure of Ephrin A2 (ephA2) Receptor Protein Kinase	0.124	339	227	89	427	2	261	2.989E-05	107
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7xbr-assembly2.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7xbr-assembly2.cif.gz_C Crystal structure of phosphorylated AtMKK5	0.149	196	125	114	309	4	151	1.167E-03	107
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5w86-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5w86-assembly3.cif.gz_C CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)	0.129	289	224	124	412	13	270	1.778E-04	107
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5mja-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5mja-assembly2.cif.gz_B Kinase domain of human EphB1 bound to a quinazoline-based inhibitor	0.137	308	224	120	427	12	272	1.196E-04	107
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3pjc-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3pjc-assembly1.cif.gz_A Crystal structure of JAK3 complexed with a potent ATP site inhibitor showing high selectivity within the Janus kinase family	0.133	303	232	124	426	12	280	2.642E-04	107
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4d0w-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4d0w-assembly1.cif.gz_A Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors	0.125	309	243	117	425	12	290	6.937E-05	107
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ux9-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ux9-assembly1.cif.gz_A Crystal structure of JNK1 bound to a MKK7 docking motif	0.147	285	199	112	396	13	246	4.024E-05	107
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1k9a-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1k9a-assembly1.cif.gz_A Crystal structure analysis of full-length carboxyl-terminal Src kinase at 2.5 A resolution	0.125	319	220	112	430	185	436	2.707E-05	107
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4i0r-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4i0r-assembly1.cif.gz_A Crystal structure of spleen tyrosine kinase complexed with 2-(3,4,5-Trimethoxy-phenyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid isopropylamide	0.130	310	219	120	429	9	261	1.321E-04	106
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6zc0-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6zc0-assembly1.cif.gz_A SYK Kinase domain in complex with azabenzimidazole inhibitor 2b	0.137	311	222	120	430	9	266	1.083E-04	106
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5tts-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5tts-assembly1.cif.gz_A Jak3 with covalent inhibitor 4	0.127	303	226	124	426	13	272	3.556E-04	106
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6x8e-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6x8e-assembly1.cif.gz_A Crystal structure of JAK2 with Compound 11	0.139	281	226	124	404	11	273	3.065E-04	106
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zc6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zc6-assembly1.cif.gz_A Crystal structure of JAK3 kinase domain in complex with an indazole substituted pyrrolopyrazine inhibitor	0.125	286	228	124	409	13	274	2.062E-04	106
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7lgs-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7lgs-assembly3.cif.gz_C Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	0.115	287	234	121	407	12	276	2.062E-04	106
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4rio-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4rio-assembly1.cif.gz_A Crystal structure of JAK3 kinase domain in complex with a pyrrolopyridazine carboxamide inhibitor	0.119	303	240	124	426	12	284	2.917E-04	106
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2itz-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2itz-assembly1.cif.gz_A Crystal structure of EGFR kinase domain L858R mutation in complex with Iressa	0.121	310	223	115	424	13	267	1.610E-04	106
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6v6a-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6v6a-assembly1.cif.gz_A Inhibitory scaffolding of the ancient MAPK, ERK7	0.129	302	236	124	425	14	285	4.228E-05	106
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5xvu-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5xvu-assembly3.cif.gz_C Crystal structure of the protein kinase CK2 catalytic domain from Plasmodium falciparum bound to ATP	0.111	270	203	121	390	32	260	7.290E-05	106
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5xzv-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5xzv-assembly2.cif.gz_B Crystal structure of Rad53 1-466 in complex with AMP-PNP	0.180	291	204	110	400	121	370	1.138E-04	106
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6brc-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6brc-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with AP26113-analog (ALK-IN-1)	0.123	188	130	121	308	7	155	2.578E-03	105
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4pv0-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4pv0-assembly1.cif.gz_A Crystal structure of spleen tyrosine kinase (Syk) in complex with an imidazopyrazine inhibitor	0.120	310	227	120	429	9	267	1.196E-04	105
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3oro-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3oro-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 4)	0.142	305	223	121	425	3	263	1.458E-04	105
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5mjb-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5mjb-assembly2.cif.gz_B Kinase domain of human EphB1, G703C mutant, covalently bound to a quinazoline-based inhibitor	0.149	316	229	112	427	7	276	1.963E-04	105
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6n7d-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6n7d-assembly1.cif.gz_A Structure of the human JAK1 kinase domain with compound 54	0.107	300	236	124	423	15	279	7.660E-05	105
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4gj3-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4gj3-assembly1.cif.gz_A Tyk2 (JH1) in complex with 2,6-dichloro-4-cyano-N-[2-({[(1R,2R)-2-fluorocyclopropyl]carbonyl}amino)pyridin-4-yl]benzamide	0.118	293	234	133	425	21	286	8.887E-05	105
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ity-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ity-assembly1.cif.gz_A Crystal structure of EGFR kinase domain in complex with Iressa	0.106	310	227	115	424	13	267	5.980E-05	105
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6qy8-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6qy8-assembly1.cif.gz_A Human CSNK2A2 bound to ERB-041	0.112	322	272	99	420	6	312	9.338E-05	105
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4dgm-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4dgm-assembly1.cif.gz_A Crystal Structure of maize CK2 in complex with the inhibitor apigenin	0.108	339	289	92	430	1	325	6.937E-05	105
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pvl-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pvl-assembly1.cif.gz_A Structure-Based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase CK2	0.112	310	259	121	430	34	326	8.887E-05	105
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2brm-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2brm-assembly1.cif.gz_A Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-Ligand Affinity	0.170	193	122	119	311	1	148	3.646E-03	104
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6zcy-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6zcy-assembly1.cif.gz_A SYK Kinase domain in complex with diamine inhibitor 16	0.124	315	227	115	429	5	264	1.532E-04	104
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7du9-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7du9-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Pralsetinib	0.131	302	232	99	400	3	270	2.393E-04	104
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3orx-assembly5.cif.gz_E	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3orx-assembly5.cif.gz_E PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	0.139	246	198	112	357	1	231	2.393E-04	104
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5tt7-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5tt7-assembly1.cif.gz_A Discovery of TAK-659, an Orally Available Investigational Inhibitor of Spleen Tyrosine Kinase (SYK)	0.130	316	233	115	430	4	272	9.338E-05	104
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5khw-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5khw-assembly2.cif.gz_B Crystal structure of JAK1 in complex with ADP	0.107	303	236	124	426	13	277	8.457E-05	104
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ggh-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ggh-assembly1.cif.gz_A Human jak1 kinase domain in complex with inhibitor	0.119	303	237	124	426	15	284	8.049E-05	104
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yjs-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yjs-assembly1.cif.gz_A THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000226	0.145	287	214	112	398	1	251	1.083E-04	103
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yjq-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yjq-assembly1.cif.gz_A SYK kinase domain in complex with inhibitor GTC000224	0.143	287	221	112	398	1	259	1.778E-04	103
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6in0-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6in0-assembly1.cif.gz_A Crystal structure of EphA3 in complex with 18-Crown-6	0.140	288	218	120	407	10	263	9.812E-05	103
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4wnm-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4wnm-assembly1.cif.gz_A SYK catalytic domain in complex with a potent triazolopyridine inhibitor	0.127	310	224	120	429	12	269	1.778E-04	103
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4gk3-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4gk3-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with ligand 87	0.138	300	234	114	413	1	273	1.138E-04	103
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uyr-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uyr-assembly1.cif.gz_A Crystal structure of TYK2 kinase domain in complex with compound 12	0.114	302	237	124	425	12	280	1.778E-04	103
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ct1-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ct1-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera in Complex with Allosteric Compound PS315 Bound to the PIF-Pocket	0.129	246	209	112	357	1	241	4.555E-04	103
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7apf-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7apf-assembly2.cif.gz_B Crystal structure of JAK3 in complex with FM601 (compound 10a)	0.115	303	236	124	426	13	280	2.514E-04	103
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3bce-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3bce-assembly3.cif.gz_C Crystal structure of the ErbB4 kinase	0.130	287	229	121	407	16	279	3.384E-04	103
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5x27-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5x27-assembly1.cif.gz_A Crystal structure of EGFR 696-1022 L858R in complex with SKLB(5)	0.119	305	223	121	425	16	269	7.290E-05	103
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6xx8-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6xx8-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal form II	0.108	332	284	103	434	7	325	2.167E-04	103
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6xx9-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6xx9-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal form III	0.104	300	249	121	420	35	313	1.868E-04	103
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vul-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vul-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1	0.147	281	189	116	396	18	240	1.868E-04	103
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5wvd-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5wvd-assembly1.cif.gz_B Structure of Mnk1 in complex with DS12881479	0.134	246	165	112	357	2	192	1.495E-03	102
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zfx-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zfx-assembly2.cif.gz_B Crystal structure of EphB1	0.135	304	203	124	427	13	248	2.393E-04	102
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg2-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xg2-assembly1.cif.gz_A Crystal structure of ligand-free Syk	0.159	267	196	132	398	16	249	3.141E-05	102
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2c3l-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2c3l-assembly1.cif.gz_A Identification of a buried pocket for potent and selective inhibition of Chk1: prediction and verification	0.174	195	121	117	311	4	151	3.646E-03	102
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5h9b-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5h9b-assembly1.cif.gz_A Drosophila CaMKII-wt in complex with a fragment of the Eag potassium channel and Mg2+/AMPPN	0.133	266	224	121	386	8	266	4.786E-04	102
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4trl-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4trl-assembly1.cif.gz_A Structure of Ephrin type-A receptor 2	0.125	303	218	124	426	19	268	1.257E-04	102
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4v0g-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4v0g-assembly1.cif.gz_A JAK3 in complex with a covalent EGFR inhibitor	0.143	289	219	124	412	10	265	3.736E-04	102
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5lvp-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5lvp-assembly4.cif.gz_D Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	0.132	281	217	112	392	4	254	2.167E-04	102
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6n78-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6n78-assembly1.cif.gz_A Structure of the human JAK1 kinase domain with compound 21	0.114	300	232	124	423	14	276	1.532E-04	102
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4e4l-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4e4l-assembly4.cif.gz_D JAK1 kinase (JH1 domain) in complex with compound 30	0.109	300	237	124	423	16	282	1.778E-04	102
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2wtk-assembly2.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2wtk-assembly2.cif.gz_C Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	0.173	194	125	117	310	4	155	1.423E-03	102
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ytf-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ytf-assembly1.cif.gz_A Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Diseases	0.130	293	231	133	425	19	284	6.602E-05	102
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6yat-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6yat-assembly1.cif.gz_A Crystal structure of STK4 (MST1) in complex with compound 6	0.160	320	236	114	433	9	290	3.384E-04	102
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2itu-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2itu-assembly1.cif.gz_A Crystal structure of EGFR kinase domain L858R mutation in complex with AFN941	0.124	287	223	121	407	17	272	9.338E-05	102
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2hel-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2hel-assembly1.cif.gz_A Crystal structure of a mutant EphA4 kinase domain (Y742A)	0.108	312	220	116	427	7	254	1.031E-04	101
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2oiq-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2oiq-assembly2.cif.gz_B Crystal Structure of chicken c-Src kinase domain in complex with the cancer drug imatinib.	0.155	277	200	119	395	8	245	4.555E-04	101
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5mja-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5mja-assembly1.cif.gz_A Kinase domain of human EphB1 bound to a quinazoline-based inhibitor	0.138	307	221	121	427	11	267	2.776E-04	101
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6n7c-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6n7c-assembly2.cif.gz_B Structure of the human JAK1 kinase domain with compound 56	0.114	300	228	124	423	15	272	1.963E-04	101
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4p5q-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4p5q-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with quinoxaline derivatives	0.136	298	232	114	411	1	269	1.196E-04	101
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6n7a-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6n7a-assembly1.cif.gz_A Structure of the human JAK1 kinase domain with compound 39	0.105	266	200	124	389	15	239	3.736E-04	101
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j95-assembly5.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j95-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.113	290	237	112	401	10	277	2.917E-04	101
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5x28-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5x28-assembly1.cif.gz_A Crystal structure of EGFR 696-1022 L858R in complex with SKLB(6)	0.106	305	226	121	425	16	269	8.457E-05	101
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6qy8-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6qy8-assembly4.cif.gz_D Human CSNK2A2 bound to ERB-041	0.115	335	266	91	425	21	322	6.283E-05	101
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6brc-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6brc-assembly2.cif.gz_B Crystal Structure of the Human CAMKK2B in complex with AP26113-analog (ALK-IN-1)	0.130	188	126	121	308	5	150	2.012E-03	100
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6i2p-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6i2p-assembly2.cif.gz_B Crystal structure of the Mycobacterium tuberculosis PknB kinase domain (L33E mutant) in complex with its substrate GarA	0.128	297	227	117	413	6	266	1.610E-04	100
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6dbm-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6dbm-assembly1.cif.gz_A Tyk2 with compound 23	0.101	295	226	131	425	20	271	1.031E-04	100
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3r1n-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3r1n-assembly1.cif.gz_A MK3 kinase bound to Compound 5b	0.131	278	202	112	389	5	237	6.442E-04	100
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5mjb-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5mjb-assembly1.cif.gz_A Kinase domain of human EphB1, G703C mutant, covalently bound to a quinazoline-based inhibitor	0.134	296	233	112	407	7	276	3.556E-04	100
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4e4l-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4e4l-assembly2.cif.gz_B JAK1 kinase (JH1 domain) in complex with compound 30	0.109	300	235	124	423	16	280	1.257E-04	100
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5i9u-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5i9u-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase	0.119	337	230	91	427	5	266	6.283E-05	100
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4k77-assembly2.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4k77-assembly2.cif.gz_A JAK1 kinase (JH1 domain) in complex with compound 6	0.119	303	234	124	426	16	282	6.602E-05	100
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6aak-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6aak-assembly1.cif.gz_B Crystal structure of JAK3 in complex with peficitinib	0.130	303	236	124	426	12	283	3.556E-04	100
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3bce-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3bce-assembly1.cif.gz_A Crystal structure of the ErbB4 kinase	0.134	287	226	121	407	16	277	4.125E-04	100
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5vcw-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5vcw-assembly2.cif.gz_B CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH Pelitinib	0.168	243	193	115	357	31	263	4.786E-04	100
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3bce-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3bce-assembly2.cif.gz_B Crystal structure of the ErbB4 kinase	0.115	304	227	121	424	16	272	2.062E-04	100
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6tpf-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6tpf-assembly1.cif.gz_A Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity	0.107	290	243	124	413	16	288	2.514E-04	100
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7aya-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7aya-assembly2.cif.gz_B Crystal structure of CK2 bound by compound 9	0.112	310	255	121	430	38	325	1.692E-04	100
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5wnh-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5wnh-assembly1.cif.gz_A X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.150	315	245	66	380	24	312	1.458E-04	100
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3cok-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3cok-assembly1.cif.gz_A Crystal structure of PLK4 kinase	0.150	294	196	108	401	4	234	2.776E-04	99
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yht-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yht-assembly2.cif.gz_B bRaf complexed with an inhibitor	0.141	310	215	112	421	4	254	5.553E-04	99
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2x8i-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2x8i-assembly1.cif.gz_A Discovery of a Novel Class of triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration	0.172	199	125	114	312	1	152	4.444E-03	99
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6aak-assembly2.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6aak-assembly2.cif.gz_D Crystal structure of JAK3 in complex with peficitinib	0.131	275	219	124	398	13	265	7.853E-04	99
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3geq-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3geq-assembly1.cif.gz_A Structural basis for the chemical rescue of Src kinase activity	0.151	284	201	112	395	15	252	1.057E-03	99
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6c7y-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6c7y-assembly1.cif.gz_A Crystal structure of inhibitory protein SOCS1 in complex with JAK1 kinase domain	0.128	267	196	124	390	12	237	5.980E-05	99
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4g2f-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4g2f-assembly1.cif.gz_A Human EphA3 kinase domain in complex with compound 7	0.134	314	227	114	427	1	263	9.338E-05	99
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7apg-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7apg-assembly4.cif.gz_D Crystal structure of JAK3 in complex with FM587 (compound 9a)	0.115	302	233	124	425	12	275	5.835E-04	99
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2gsf-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2gsf-assembly1.cif.gz_A The Human Epha3 Receptor Tyrosine Kinase and Juxtamembrane Region	0.136	322	232	114	435	7	276	8.457E-05	99
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7jxh-assembly8.cif.gz_H	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7jxh-assembly8.cif.gz_H HER2 in complex with JBJ-08-178-01	0.123	287	229	121	407	14	275	1.321E-04	99
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4a07-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4a07-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Allosteric Activator PS171 Bound to the PIF-Pocket	0.143	246	205	112	357	1	240	7.113E-04	99
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7jxh-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7jxh-assembly4.cif.gz_D HER2 in complex with JBJ-08-178-01	0.118	305	228	121	425	14	273	8.457E-05	99
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6agx-assembly2.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6agx-assembly2.cif.gz_C The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	0.124	317	239	112	428	10	283	2.167E-04	99
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4tks-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4tks-assembly1.cif.gz_A Native-SAD phasing for human EGFR kinase domain.	0.115	310	231	115	424	13	274	8.887E-05	99
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ydj-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ydj-assembly1.cif.gz_A Discovery of Checkpoint Kinase Inhibitor AZD7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas	0.155	189	117	120	308	1	140	4.907E-03	98
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uyv-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uyv-assembly4.cif.gz_D Crystal structure of JAK3 kinase domain in complex with compound 25	0.141	286	218	124	409	13	267	5.835E-04	98
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7dua-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7dua-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with 4-amino-7-(1-methylcyclopropyl)-N-(5-methyl-1H-pyrazol-3-yl)pyrrolo[2,3-d]pyrimidine-5-carboxamide	0.134	288	219	113	400	18	271	3.556E-04	98
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5lvp-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5lvp-assembly2.cif.gz_B Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	0.137	246	198	112	357	4	234	6.131E-04	98
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5mrd-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5mrd-assembly1.cif.gz_A Human PDK1-PKCiota Kinase Chimera in Complex with Allosteric Compound PS267 Bound to the PIF-Pocket	0.136	246	207	112	357	1	241	3.556E-04	98
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2itq-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2itq-assembly1.cif.gz_A Crystal structure of EGFR kinase domain G719S mutation in complex with AFN941	0.121	304	229	121	424	16	277	1.458E-04	98
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5gmp-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5gmp-assembly1.cif.gz_A Crystal structure of EGFR 696-1022 T790M in complex with XTF-262	0.123	287	223	121	407	17	271	1.321E-04	98
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ghm-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ghm-assembly1.cif.gz_A Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-895449	0.118	290	244	112	401	16	293	1.196E-04	98
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5xzw-assembly3.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5xzw-assembly3.cif.gz_A Crystal structure of Rad53 1-466	0.154	280	204	79	358	122	363	3.384E-04	98
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2zv8-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2zv8-assembly1.cif.gz_A Lyn Tyrosine Kinase Domain-AMP-PNP complex	0.116	284	217	112	395	5	250	1.167E-03	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7xbr-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7xbr-assembly1.cif.gz_A Crystal structure of phosphorylated AtMKK5	0.155	177	111	133	309	17	148	4.230E-03	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2bdf-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2bdf-assembly2.cif.gz_B Src kinase in complex with inhibitor AP23451	0.153	277	202	119	395	11	250	9.574E-04	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3f6x-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3f6x-assembly2.cif.gz_B c-Src kinase domain in complex with small molecule inhibitor	0.148	284	204	112	395	8	247	7.113E-04	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ugl-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ugl-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	0.122	316	227	113	428	11	270	3.736E-04	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ttv-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ttv-assembly1.cif.gz_A Jak3 with covalent inhibitor 6	0.112	275	233	124	398	13	275	1.226E-03	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5e1e-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5e1e-assembly1.cif.gz_A Human JAK1 kinase in complex with compound 30 at 2.30 Angstroms resolution	0.114	300	235	124	423	15	280	1.196E-04	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6smb-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6smb-assembly2.cif.gz_B Human jak1 kinase domain in complex with inhibitor	0.113	303	234	124	426	17	281	1.778E-04	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6jrk-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6jrk-assembly1.cif.gz_A The structure of co-crystals of 8r-B-EGFR WT complex	0.101	304	214	121	424	17	255	1.196E-04	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2psq-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2psq-assembly1.cif.gz_A Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domain	0.128	318	242	112	429	9	286	6.131E-04	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ito-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ito-assembly1.cif.gz_A Crystal structure of EGFR kinase domain G719S mutation in complex with Iressa	0.131	310	222	115	424	14	269	3.384E-04	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8f1h-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8f1h-assembly1.cif.gz_A EGFR kinase in complex with TAS6417 (CLN-081)	0.123	310	232	115	424	13	277	2.642E-04	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3w2p-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3w2p-assembly1.cif.gz_A EGFR Kinase domain T790M/L858R mutant with compound 2	0.111	304	232	121	424	16	277	1.257E-04	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6s8a-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6s8a-assembly1.cif.gz_A Crystal Structure of EGFR-T790M/C797S in Complex with Covalent Pyrrolopyrimidine 19h	0.110	304	232	121	424	16	277	1.388E-04	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6lnm-assembly3.cif.gz_E	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6lnm-assembly3.cif.gz_E Crystal structure of CASK-CaMK in complex with Mint1-CID	0.131	323	262	114	436	3	304	1.610E-04	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5mxx-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5mxx-assembly1.cif.gz_A Crystal structure of human SR protein kinase 1 (SRPK1) in complex with compound 1	0.102	195	171	110	304	17	207	2.846E-03	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yve-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yve-assembly1.cif.gz_A ROCK 1 bound to methoxyphenyl thiazole inhibitor	0.143	338	247	66	403	24	312	1.083E-04	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hvu-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hvu-assembly1.cif.gz_B Rho-associated protein kinase 1 (ROCK 1) in complex with a pyridine thiazole piperidine inhibitor	0.139	334	245	66	399	25	309	9.338E-05	97
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3kul-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3kul-assembly1.cif.gz_A Kinase domain of human ephrin type-A receptor 8 (EPHA8)	0.122	313	228	112	424	4	264	5.835E-04	96
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2wtk-assembly1.cif.gz_F	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2wtk-assembly1.cif.gz_F Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	0.160	194	129	117	310	1	155	2.991E-03	96
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zew-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zew-assembly1.cif.gz_A Crystal structure of EphB4 in complex with staurosporine	0.111	316	233	112	427	2	264	2.642E-04	96
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7du8-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7du8-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Selpercatinib	0.125	297	235	102	398	3	272	2.642E-04	96
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3jy9-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3jy9-assembly1.cif.gz_A Janus Kinase 2 Inhibitors	0.128	293	230	133	425	19	283	3.384E-04	96
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4riy-assembly2.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4riy-assembly2.cif.gz_D Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-E909G mutation	0.117	287	234	121	407	25	290	2.167E-04	96
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2j5e-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2j5e-assembly1.cif.gz_A Crystal structure of EGFR kinase domain in complex with an irreversible inhibitor 13-jab	0.111	293	237	115	407	14	281	3.384E-04	96
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6isj-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6isj-assembly1.cif.gz_A Crystal structure of CX-4945 bound CK2 alpha from C. neoformans	0.132	334	279	93	426	1	323	1.083E-04	96
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qny-assembly3.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qny-assembly3.cif.gz_A-2 Crystal structure of MapK from Leishmania donovani, LDBPK_331470	0.154	308	244	124	412	22	329	8.457E-05	96
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5kkt-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5kkt-assembly1.cif.gz_A ROCK 1 bound to azaindole thiazole piperazine inhibitor	0.132	334	247	66	399	24	308	1.778E-04	96
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zfx-assembly7.cif.gz_G	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zfx-assembly7.cif.gz_G Crystal structure of EphB1	0.116	295	202	133	427	19	247	2.776E-04	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5oq8-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5oq8-assembly1.cif.gz_A Structure of CHK1 12-pt. mutant complex with arylbenzamide LRRK2 inhibitor	0.170	199	124	113	311	1	150	6.605E-03	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2xyn-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2xyn-assembly2.cif.gz_B HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680	0.127	306	220	121	426	9	261	1.571E-03	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4o2p-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4o2p-assembly2.cif.gz_B Kinase domain of cSrc in complex with a substituted pyrazolopyrimidine	0.141	284	204	112	395	7	245	7.474E-04	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6bku-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6bku-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B bound to GSK650394	0.145	190	130	119	308	5	157	3.831E-03	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6jlr-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6jlr-assembly1.cif.gz_A Crystal structure of wild type MNK2 in complex with inhibitor	0.141	297	221	112	408	7	264	5.553E-04	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6n7c-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6n7c-assembly1.cif.gz_A Structure of the human JAK1 kinase domain with compound 56	0.112	300	230	124	423	15	274	1.610E-04	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6yat-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6yat-assembly1.cif.gz_B Crystal structure of STK4 (MST1) in complex with compound 6	0.160	310	230	120	429	1	275	7.113E-04	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8d6e-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8d6e-assembly1.cif.gz_B Crystal Structure of Human Myt1 Kinase domain Bounded with RP-6306	0.170	239	192	119	357	28	259	4.125E-04	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6tpe-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6tpe-assembly1.cif.gz_A Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity	0.090	267	209	124	390	16	246	4.125E-04	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pwl-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pwl-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	0.125	317	239	112	428	10	283	4.786E-04	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6glb-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6glb-assembly2.cif.gz_B Crystal structure of JAK3 in complex with Compound 20 (FM484)	0.121	303	236	124	426	14	283	5.835E-04	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5y9t-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5y9t-assembly1.cif.gz_A Crystal Structure of EGFR T790M mutant in complex with naquotinib	0.118	304	228	121	424	16	275	2.062E-04	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3w2o-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3w2o-assembly1.cif.gz_A EGFR Kinase domain T790M/L858R Mutant with TAK-285	0.111	304	232	121	424	16	277	8.457E-05	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ekk-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ekk-assembly1.cif.gz_A Akt1 with AMP-PNP	0.126	276	234	119	394	5	273	2.917E-04	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ux9-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ux9-assembly2.cif.gz_B Crystal structure of JNK1 bound to a MKK7 docking motif	0.131	309	247	116	400	17	325	1.388E-04	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3o2m-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3o2m-assembly1.cif.gz_A Crystal Structure of JNK1-alpha1 isoform complex with a biaryl tetrazol (A-82118)	0.115	342	279	112	427	14	355	5.154E-05	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2f2u-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2f2u-assembly1.cif.gz_A-2 crystal structure of the Rho-kinase kinase domain	0.133	375	236	16	390	19	291	7.660E-05	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ax8-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ax8-assembly1.cif.gz_A Medium resolution structure of the bifunctional kinase- methyltransferase WbdD	0.157	276	180	112	387	217	430	1.868E-04	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4oav-assembly1.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4oav-assembly1.cif.gz_D Complete human RNase L in complex with 2-5A (5'-ppp heptamer), AMPPCP and RNA substrate.	0.128	352	273	12	363	217	530	1.778E-04	95
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zfx-assembly6.cif.gz_F	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zfx-assembly6.cif.gz_F Crystal structure of EphB1	0.137	304	203	124	427	12	247	6.442E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2c3j-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2c3j-assembly1.cif.gz_A Identification of a buried pocket for potent and selective inhibition of Chk1: prediction and verification	0.171	193	119	119	311	2	146	5.982E-03	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hzv-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hzv-assembly2.cif.gz_B HUMAN JAK3 IN COMPLEX WITH LASW959 PROTEIN IN COMPLEX WITH LIGAND	0.132	286	220	124	409	12	265	5.835E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4gk4-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4gk4-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with ligand 90	0.125	314	231	114	427	1	265	1.692E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qt1-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qt1-assembly1.cif.gz_A JAK3 kinase domain in complex with 1-[(3S)-1-isobutylsulfonyl-3-piperidyl]-3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)urea	0.112	303	231	124	426	13	273	1.057E-03	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7t4j-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7t4j-assembly1.cif.gz_B Crystal Structure of EGFR_D770_N771insNPG/V948R in complex with TAK-788	0.108	304	227	121	424	12	267	3.736E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zc6-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zc6-assembly2.cif.gz_B Crystal structure of JAK3 kinase domain in complex with an indazole substituted pyrrolopyrazine inhibitor	0.136	289	223	124	412	14	272	4.786E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8a5j-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8a5j-assembly1.cif.gz_A Crystal structure of Human STE20-like kinase 1, MST1 in complex with compound XMU-MP-1	0.151	313	233	117	429	2	276	7.474E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3hrc-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3hrc-assembly1.cif.gz_A Crystal structure of a mutant of human PDK1 Kinase domain in complex with ATP	0.140	246	203	112	357	1	237	1.111E-03	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3lxp-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3lxp-assembly1.cif.gz_A Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6	0.112	299	233	131	429	21	283	2.776E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6v6q-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6v6q-assembly1.cif.gz_A Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.128	305	230	124	428	20	284	7.474E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7kia-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7kia-assembly2.cif.gz_B Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	0.117	317	242	113	429	11	285	8.671E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6agx-assembly2.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6agx-assembly2.cif.gz_D The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	0.118	317	253	112	428	10	297	3.556E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5czh-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5czh-assembly1.cif.gz_A EGFR L858R MUTANT IN COMPLEX WITH AN OPTIMAL PEPTIDE SUBSTRATE	0.112	304	232	121	424	17	278	1.868E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ocb-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ocb-assembly1.cif.gz_A Akt1 kinase domain with pyrrolopyrimidine inhibitor	0.121	295	240	121	415	7	280	4.786E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5cvf-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5cvf-assembly1.cif.gz_A Crystal Structure of CK2alpha with Compound 5 bound	0.121	289	243	121	409	37	314	3.736E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6xx7-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6xx7-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal in complex with ANP	0.103	334	274	110	443	21	327	2.393E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ux9-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ux9-assembly3.cif.gz_C Crystal structure of JNK1 bound to a MKK7 docking motif	0.132	319	253	112	404	13	331	2.277E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ocg-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ocg-assembly1.cif.gz_A P38 Alpha kinase complexed with a 5-amino-pyrazole based inhibitor	0.164	286	229	116	401	19	293	2.393E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4r3c-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4r3c-assembly1.cif.gz_A Crystal structure of p38 alpha MAP kinase in complex with a novel isoform selective drug candidate	0.134	267	175	116	382	19	221	3.065E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6yzh-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6yzh-assembly1.cif.gz_A Crystal structure of P8C9 bound to CK2alpha	0.115	289	247	121	409	52	331	2.167E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vug-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vug-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M2 in MAP kinase JNK1	0.134	266	183	116	381	18	229	4.555E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4l6q-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4l6q-assembly1.cif.gz_A ROCK2 in complex with benzoxaborole	0.142	325	233	66	390	19	291	2.167E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4azs-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4azs-assembly1.cif.gz_A High resolution (2.2 A) crystal structure of WbdD.	0.159	276	172	112	387	217	422	3.221E-04	94
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3dqx-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3dqx-assembly2.cif.gz_B chicken c-Src kinase domain in complex with ATPgS	0.152	277	204	119	395	7	248	1.289E-03	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uyu-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uyu-assembly1.cif.gz_A Crystal structure of TYK2 kinase domain in complex with compound 30	0.118	295	218	131	425	20	267	2.642E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4gfo-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4gfo-assembly1.cif.gz_A TYK2 kinase (JH1 domain) with 2,6-DICHLORO-N-(2-OXO-2,5-DIHYDROPYRIDIN-4-YL)BENZAMIDE	0.097	306	232	124	429	12	269	9.111E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4un0-assembly2.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4un0-assembly2.cif.gz_D Crystal structure of the human CDK12-cyclinK complex	0.145	292	227	118	409	2	267	1.196E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2vgo-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2vgo-assembly2.cif.gz_B Crystal structure of Aurora B kinase in complex with Reversine inhibitor	0.118	327	232	92	418	4	267	3.384E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7vdp-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7vdp-assembly2.cif.gz_B The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 1	0.125	301	238	120	420	1	273	1.057E-03	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8pqb-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8pqb-assembly1.cif.gz_A c-KIT kinase domain in complex with avapritinib derivative 8	0.144	306	218	120	425	24	279	4.335E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3lxl-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3lxl-assembly1.cif.gz_A Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6	0.123	267	203	124	390	13	245	9.574E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6gla-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6gla-assembly2.cif.gz_B Crystal structure of JAK3 in complex with Compound 11 (FM481)	0.122	303	234	124	426	14	281	7.113E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7ju5-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7ju5-assembly1.cif.gz_A Structure of RET protein tyrosine kinase in complex with pralsetinib	0.120	311	229	120	430	26	286	4.555E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6tsz-assembly1.cif.gz_U	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6tsz-assembly1.cif.gz_U The ULK4 Pseudokinase Domain Bound To ATPgammaS	0.131	296	237	115	410	5	278	5.835E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5vd3-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5vd3-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN (de-phosphorylated) IN COMPLEX WITH SARACATINIB	0.159	246	198	112	357	37	272	9.111E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vh4-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vh4-assembly1.cif.gz_A Wild type EGFR in complex with LN2380	0.113	305	225	121	425	17	271	2.776E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4jrv-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4jrv-assembly1.cif.gz_A-2 Crystal structure of EGFR kinase domain in complex with compound 4c	0.115	304	228	121	424	17	275	3.065E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4jq7-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4jq7-assembly1.cif.gz_A Crystal structure of EGFR kinase domain in complex with compound 2a	0.112	305	233	121	425	17	279	3.926E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4g5j-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4g5j-assembly1.cif.gz_A Crystal structure of EGFR kinase in complex with BIBW2992	0.112	309	221	115	423	14	263	4.125E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ocb-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ocb-assembly2.cif.gz_B Akt1 kinase domain with pyrrolopyrimidine inhibitor	0.134	301	233	121	421	7	276	4.125E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r7i-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r7i-assembly2.cif.gz_B Crystal structure of catalytic subunit of protein kinase CK2	0.111	304	252	121	424	38	321	2.277E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r7i-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r7i-assembly4.cif.gz_D Crystal structure of catalytic subunit of protein kinase CK2	0.110	289	242	121	409	38	310	1.963E-04	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3oz6-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3oz6-assembly1.cif.gz_B Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	0.135	291	221	133	423	21	277	6.602E-05	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fad-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fad-assembly3.cif.gz_C SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	0.137	197	163	110	306	18	207	1.915E-03	93
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7xbr-assembly1.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7xbr-assembly1.cif.gz_D Crystal structure of phosphorylated AtMKK5	0.141	176	112	134	309	11	141	4.670E-03	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fk3-assembly3.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fk3-assembly3.cif.gz_B B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203	0.129	286	216	119	404	8	256	3.065E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hzv-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hzv-assembly1.cif.gz_A HUMAN JAK3 IN COMPLEX WITH LASW959 PROTEIN IN COMPLEX WITH LIGAND	0.133	301	218	124	424	12	264	8.252E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5w86-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5w86-assembly2.cif.gz_B CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)	0.132	280	215	133	412	17	265	8.671E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3eqp-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3eqp-assembly1.cif.gz_B Crystal Structure of Ack1 with compound T95	0.123	297	217	124	420	14	261	1.167E-03	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8bfs-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8bfs-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) in complex with FZ326	0.146	312	225	114	425	8	271	7.853E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6aak-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6aak-assembly1.cif.gz_A Crystal structure of JAK3 in complex with peficitinib	0.146	288	225	124	411	12	276	7.474E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5i9v-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5i9v-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with AGS	0.116	307	224	121	427	9	262	4.335E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6dbn-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6dbn-assembly1.cif.gz_A Jak1 with compound 23	0.100	300	240	124	423	13	280	6.769E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j99-assembly6.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j99-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	0.097	312	240	113	424	13	279	6.769E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6tpe-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6tpe-assembly2.cif.gz_B Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity	0.097	267	207	124	390	16	245	5.553E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6agx-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6agx-assembly1.cif.gz_A The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	0.125	317	240	112	428	10	284	6.131E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3b2t-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3b2t-assembly1.cif.gz_A Structure of phosphotransferase	0.122	310	234	124	433	22	288	1.651E-03	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4riy-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4riy-assembly1.cif.gz_B Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-E909G mutation	0.125	304	225	121	424	25	282	2.642E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2itt-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2itt-assembly1.cif.gz_A Crystal structure of EGFR kinase domain L858R mutation in complex with AEE788	0.107	304	225	121	424	16	268	2.514E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6jz0-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6jz0-assembly1.cif.gz_A Crystal structure of EGFR kinase domain in complex with compound 78	0.123	287	232	121	407	17	281	6.131E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6kmh-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6kmh-assembly2.cif.gz_B The crystal structure of CASK/Mint1 complex	0.143	303	246	115	402	5	307	4.555E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7q4a-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7q4a-assembly1.cif.gz_A Toxoplasma gondii PRP4K kinase domain (L715F) bound to altiratinib	0.144	316	263	112	419	10	325	2.917E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4myg-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4myg-assembly2.cif.gz_B MAPK13, active form	0.128	303	243	116	418	9	288	2.167E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2b9i-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2b9i-assembly1.cif.gz_A Crystal structure of Fus3 with a docking motif from Msg5	0.139	326	264	117	424	9	334	1.868E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3fhi-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3fhi-assembly1.cif.gz_A Crystal structure of a complex between the catalytic and regulatory (RI{alpha}) subunits of PKA	0.113	317	260	99	415	7	300	1.321E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3v6s-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3v6s-assembly2.cif.gz_B Discovery of potent and selective covalent inhibitors of JNK	0.133	315	251	112	426	14	304	4.335E-04	92
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zfx-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zfx-assembly4.cif.gz_D Crystal structure of EphB1	0.134	308	215	120	427	10	258	6.769E-04	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6aam-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6aam-assembly1.cif.gz_A Crystal structure of TYK2 in complex with peficitinib	0.108	299	222	133	431	19	268	7.474E-04	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3eqr-assembly3.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3eqr-assembly3.cif.gz_B Crystal Structure of Ack1 with compound T74	0.124	297	219	124	420	14	264	1.111E-03	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ion-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ion-assembly1.cif.gz_A PDK1 in complex with Compound 8h	0.122	291	205	112	402	3	236	7.853E-04	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6db4-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6db4-assembly1.cif.gz_A JAK3 with Cyanamide CP34	0.122	303	229	124	426	13	274	1.006E-03	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1oky-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1oky-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with staurosporine	0.132	246	202	112	357	6	239	1.006E-03	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r2p-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r2p-assembly1.cif.gz_A Kinase domain of human ephrin type-A receptor 5 (EphA5)	0.137	282	228	114	395	2	266	3.221E-04	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7vra-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7vra-assembly1.cif.gz_A The crystal structure of EGFR T790M/C797S with the inhibitor HC5476	0.123	304	216	121	424	17	263	4.555E-04	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1xo2-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1xo2-assembly1.cif.gz_B Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin	0.116	302	247	119	420	1	280	1.006E-03	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j99-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j99-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	0.120	316	246	113	428	11	290	9.574E-04	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4r5s-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4r5s-assembly1.cif.gz_A Crystal structure of EGFR 696-1022 L858R in complex with FIIN-3	0.129	287	223	121	407	16	272	4.555E-04	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r0i-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r0i-assembly2.cif.gz_B Crystal structure of a kinase MARK2/Par-1 mutant	0.140	290	241	124	404	10	299	2.167E-04	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2gcd-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2gcd-assembly1.cif.gz_A TAO2 kinase domain-staurosporine structure	0.132	323	248	112	434	11	297	4.555E-04	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7zym-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7zym-assembly1.cif.gz_A Crystal Structure of EGFR-T790M/C797S in Complex with Brigatinib	0.134	287	226	121	407	17	278	3.221E-04	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3oz6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3oz6-assembly1.cif.gz_A Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	0.138	290	226	134	423	15	277	8.049E-05	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3v6r-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3v6r-assembly1.cif.gz_A Discovery of potent and selective covalent inhibitors of JNK	0.132	315	260	112	426	14	313	5.029E-04	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vuh-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vuh-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M3 in MAP kinase JNK1	0.123	335	273	116	427	18	352	6.602E-05	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1k9a-assembly5.cif.gz_E	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1k9a-assembly5.cif.gz_E Crystal structure analysis of full-length carboxyl-terminal Src kinase at 2.5 A resolution	0.115	363	257	66	428	145	435	3.829E-05	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4oav-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4oav-assembly1.cif.gz_B Complete human RNase L in complex with 2-5A (5'-ppp heptamer), AMPPCP and RNA substrate.	0.117	365	272	13	377	220	528	4.335E-04	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7elw-assembly1.cif.gz_b	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7elw-assembly1.cif.gz_b Crystal structure of RNase L in complex with Myricetin	0.129	325	245	50	374	261	542	2.642E-04	91
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2cgw-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2cgw-assembly1.cif.gz_A Identification of chemically diverse Chk1 inhibitors by receptor- based virtual screening	0.177	193	122	119	311	2	150	6.286E-03	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zfx-assembly5.cif.gz_E	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zfx-assembly5.cif.gz_E Crystal structure of EphB1	0.126	275	209	133	407	19	258	7.113E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r7b-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r7b-assembly1.cif.gz_A Crystal Structure of the Phosphoinositide-dependent Kinase-1 (PDK-1)Catalytic Domain bound to a dibenzonaphthyridine inhibitor	0.126	246	199	112	357	3	231	1.111E-03	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3orz-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3orz-assembly3.cif.gz_C PDK1 mutant bound to allosteric disulfide fragment activator 2A2	0.131	246	200	112	357	4	234	1.823E-03	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8tuc-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8tuc-assembly1.cif.gz_A Unphosphorylated CaMKK2 in complex with CC-8977	0.115	282	237	120	401	8	276	5.284E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ydi-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ydi-assembly1.cif.gz_A Discovery of Checkpoint Kinase Inhibitor AZD7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas	0.172	195	128	117	311	4	158	4.444E-03	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1gjo-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1gjo-assembly1.cif.gz_A The FGFr2 tyrosine kinase domain	0.127	317	235	112	428	10	279	1.226E-03	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6rse-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6rse-assembly2.cif.gz_B Structure based optimization of JAK1-ATP binding pocket Inhibitors in the aminopyrazole class	0.112	300	235	124	423	15	280	2.514E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ehz-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ehz-assembly2.cif.gz_B The Jak1 kinase domain in complex with inhibitor	0.120	303	233	124	426	15	280	7.474E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hvj-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hvj-assembly1.cif.gz_A Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	0.106	306	238	124	429	15	281	9.574E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ri1-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ri1-assembly2.cif.gz_B Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069	0.114	315	241	113	427	10	282	1.354E-03	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hzu-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hzu-assembly2.cif.gz_B HUMAN JAK1 IN COMPLEX WITH LASW1393	0.122	300	236	124	423	15	284	1.031E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ri1-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ri1-assembly1.cif.gz_A Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069	0.118	317	242	113	429	10	284	9.111E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3kxx-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3kxx-assembly4.cif.gz_D Structure of the mutant Fibroblast Growth Factor receptor 1	0.129	318	234	112	429	18	287	5.284E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5amn-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5amn-assembly1.cif.gz_A-2 The Discovery of 2-Substituted Phenol Quinazolines as Potent and Selective RET Kinase Inhibitors	0.127	279	227	120	398	24	284	4.555E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4i21-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4i21-assembly1.cif.gz_A Crystal structure of L858R + T790M EGFR kinase domain in complex with MIG6 peptide	0.133	289	231	119	407	8	275	6.769E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5cas-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5cas-assembly1.cif.gz_A EGFR kinase domain mutant "TMLR" with compound 41a	0.110	304	217	121	424	17	261	3.556E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8h7x-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8h7x-assembly1.cif.gz_A Crystal structure of EGFR T790M/C797S mutant in complex with brigatinib	0.127	305	229	121	425	16	278	5.284E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1m17-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1m17-assembly1.cif.gz_A Epidermal Growth Factor Receptor tyrosine kinase domain with 4-anilinoquinazoline inhibitor erlotinib	0.106	304	233	121	424	17	278	3.221E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8d76-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8d76-assembly2.cif.gz_B Crystal Structure of EGFR LRTM with compound 24	0.109	336	264	124	459	15	311	4.786E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6z45-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6z45-assembly1.cif.gz_A CDK9-Cyclin-T1 complex bound by compound 24	0.132	277	233	125	394	20	296	4.786E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5otl-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5otl-assembly1.cif.gz_A The crystal structure of CK2alpha in complex with compound 29	0.125	300	252	110	409	23	311	2.917E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1ukh-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1ukh-assembly1.cif.gz_A Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125	0.136	314	263	116	429	16	320	2.776E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5h8g-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5h8g-assembly1.cif.gz_A Crystal structure of CK2 with compound 7b	0.114	329	279	92	420	1	316	3.065E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6lnm-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6lnm-assembly1.cif.gz_A Crystal structure of CASK-CaMK in complex with Mint1-CID	0.121	320	261	114	433	3	300	4.335E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3iw4-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3iw4-assembly2.cif.gz_B Crystal structure of PKC alpha in complex with NVP-AEB071	0.129	279	231	117	395	9	274	1.423E-03	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5nho-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5nho-assembly1.cif.gz_A Human Erk2 with an Erk1/2 inhibitor	0.143	268	189	114	381	11	231	4.555E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6eq9-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6eq9-assembly1.cif.gz_A Crystal structure of JNK3 in complex with AMP-PCP	0.148	266	178	116	381	17	226	1.289E-03	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4h3b-assembly2.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4h3b-assembly2.cif.gz_C Crystal Structure of JNK3 in Complex with SAB Peptide	0.139	266	184	116	381	18	232	3.926E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vuk-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vuk-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M5 in MAP kinase JNK1	0.122	332	270	116	424	18	349	8.049E-05	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fad-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fad-assembly4.cif.gz_D SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	0.117	197	164	110	306	18	204	5.418E-03	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6b2e-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6b2e-assembly1.cif.gz_A Structure of full length human AMPK (a2b2g1) in complex with a small molecule activator SC4.	0.149	257	195	124	380	12	241	7.113E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8sap-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8sap-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase ThurKC	0.103	273	223	117	389	208	457	6.442E-04	90
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2brh-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2brh-assembly1.cif.gz_A Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-Ligand Affinity	0.161	190	117	119	308	2	142	4.907E-03	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6cd6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6cd6-assembly1.cif.gz_A Crystal Structure of the Human CAMKK1A in complex with GSK650394	0.128	297	217	120	416	5	254	1.423E-03	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4rvk-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4rvk-assembly1.cif.gz_A CHK1 kinase domain with diazacarbazole compound 8: N-[3-(6-cyano-9H-pyrrolo[2,3-b:5,4-c']dipyridin-3-yl)phenyl]acetamide	0.170	195	122	117	311	3	150	7.293E-03	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xli-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xli-assembly2.cif.gz_B Crystal structure of Abl2/Arg kinase in complex with dasatinib	0.131	297	212	133	429	19	263	1.289E-03	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4id7-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4id7-assembly1.cif.gz_A-2 ACK1 kinase in complex with the inhibitor cis-3-[8-amino-1-(4-phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol	0.117	302	223	124	425	14	267	6.131E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ova-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ova-assembly1.cif.gz_A Crystal Structure of TYK2 with novel pyrrolidinone inhibitor	0.110	303	228	124	426	14	270	1.111E-03	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ewh-assembly1.cif.gz_B-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ewh-assembly1.cif.gz_B-2 Co-crystal structure of ACK1 with inhibitor	0.114	300	228	121	420	10	267	1.651E-03	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5f20-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5f20-assembly1.cif.gz_A Structure of TYK2 with inhibitor 4: 3-azanyl-5-(2-methylphenyl)-7-(1-methylpyrazol-3-yl)-1~{H}-pyrazolo[4,3-c]pyridin-4-one	0.100	274	227	131	404	21	273	5.029E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ivs-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ivs-assembly1.cif.gz_B Crystal structure of non-phosphorylated RET tyrosine kinase domain	0.126	300	233	99	398	3	270	5.029E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zc6-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zc6-assembly3.cif.gz_C Crystal structure of JAK3 kinase domain in complex with an indazole substituted pyrrolopyrazine inhibitor	0.135	289	223	124	412	13	271	9.111E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1uu7-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1uu7-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-2	0.140	246	201	112	357	5	239	1.354E-03	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uyv-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uyv-assembly3.cif.gz_C Crystal structure of JAK3 kinase domain in complex with compound 25	0.136	288	227	124	411	15	278	1.823E-03	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7a6i-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7a6i-assembly1.cif.gz_A Crystal Structure of EGFR-T790M/V948R in Complex with LDC8201	0.126	304	228	121	424	10	271	1.111E-03	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5uhn-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5uhn-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	0.110	305	235	124	428	17	281	1.057E-03	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7ju6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7ju6-assembly1.cif.gz_A Structure of RET protein tyrosine kinase in complex with selpercatinib	0.138	288	239	113	400	8	285	5.553E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2x2l-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2x2l-assembly1.cif.gz_A-2 Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	0.127	288	234	113	400	19	287	8.252E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1yvj-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1yvj-assembly1.cif.gz_A Crystal structure of the Jak3 kinase domain in complex with a staurosporine analogue	0.115	303	241	124	426	13	285	3.302E-03	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5tq4-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5tq4-assembly1.cif.gz_A Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin	0.116	304	246	124	427	13	291	6.769E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4e5w-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4e5w-assembly1.cif.gz_A JAK1 kinase (JH1 domain) in complex with compound 26	0.113	293	230	131	423	34	293	1.321E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8pqi-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8pqi-assembly1.cif.gz_A PDGFRA T674I mutant kinase domain in complex with avapritinib derivative 9	0.104	315	234	112	426	22	283	9.111E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hcy-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hcy-assembly1.cif.gz_A EGFR kinase domain mutant "TMLR" with 3-carboxamide azaindole compound 13	0.114	304	218	121	424	17	263	2.062E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4li5-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4li5-assembly1.cif.gz_A EGFR-K IN COMPLEX WITH N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxy-phenyl] Prop-2-enamide	0.109	304	233	121	424	20	281	1.778E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ugb-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ugb-assembly1.cif.gz_A Crystal structure of the EGFR kinase domain in complex with 4-(4-{[2-{[(3S)-1-acetylpyrrolidin-3-yl]amino}-9-(propan-2-yl)-9H-purin-6-yl]amino}phenyl)-1-methylpiperazin-1-ium	0.122	304	227	121	424	18	277	8.252E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2jdo-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2jdo-assembly1.cif.gz_A STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE	0.134	294	235	121	414	7	278	7.474E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5izj-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5izj-assembly1.cif.gz_A Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411	0.121	299	254	99	397	6	295	3.384E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fj0-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fj0-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	0.154	192	128	117	308	14	165	6.605E-03	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3cd3-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3cd3-assembly1.cif.gz_A Crystal structure of phosphorylated human feline sarcoma viral oncogene homologue (v-FES) in complex with staurosporine and a consensus peptide	0.146	302	214	124	425	101	352	5.835E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7jou-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7jou-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK1) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.135	327	279	64	390	21	344	3.736E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5bml-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5bml-assembly1.cif.gz_A ROCK 1 bound to a pyridine thiazole inhibitor	0.131	334	249	66	399	24	310	4.125E-04	89
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8six-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8six-assembly1.cif.gz_A Structure of Compound 13 bound to the CHK1 10-point mutant	0.157	192	122	120	311	1	146	1.257E-02	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6bqq-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6bqq-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with BI2526	0.109	282	233	120	401	8	270	2.453E-03	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4hvd-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4hvd-assembly1.cif.gz_A JAK3 kinase domain in complex with 2-Cyclopropyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((S)-1,2,2-trimethyl-propyl)-amide	0.120	303	230	124	426	12	273	2.846E-03	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6t8x-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6t8x-assembly1.cif.gz_B Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide	0.115	292	232	112	403	13	275	7.474E-04	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4zji-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4zji-assembly2.cif.gz_B PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine	0.138	308	226	112	419	11	273	7.474E-04	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7ozy-assembly2.cif.gz_BBB	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7ozy-assembly2.cif.gz_BBB FGFR2 kinase domain (residues 461-763) in complex with 38.	0.110	311	237	113	423	11	277	1.111E-03	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j99-assembly5.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j99-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	0.120	316	235	113	428	12	279	5.835E-04	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4b6l-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4b6l-assembly1.cif.gz_A Discovery of Oral Polo-Like Kinase (PLK) Inhibitors with Enhanced Selectivity Profile using Residue Targeted Drug Design	0.133	284	238	112	395	4	278	1.354E-03	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j95-assembly6.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j95-assembly6.cif.gz_C Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.110	316	240	112	427	9	279	1.057E-03	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv3-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv3-assembly1.cif.gz_A Crystal structure of EGFR_DMX in complex with covalently bound fragment 4	0.132	287	227	121	407	17	279	4.555E-04	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3qkm-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3qkm-assembly1.cif.gz_A Spirocyclic sulfonamides as AKT inhibitors	0.126	304	243	112	415	2	280	6.442E-04	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2p33-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2p33-assembly1.cif.gz_A Synthesis and SAR of Aminopyrimidines as Novel c-Jun N-Terminal Kinase (JNK) Inhibitors	0.141	315	256	112	426	14	312	1.006E-03	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4wb6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4wb6-assembly1.cif.gz_A Crystal structure of a L205R mutant of human cAMP-dependent protein kinase A (catalytic alpha subunit)	0.148	317	250	99	415	7	300	9.812E-05	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6yqj-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6yqj-assembly1.cif.gz_A Crystal structure of cAMP-dependent Protein Kinase (PKA) in complex with open-chain Fasudil-derivative 2-[isoquinolin-5-ylsulfonyl(propyl)amino]ethylazanium (soaked)	0.123	335	260	81	415	15	312	1.031E-04	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vui-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vui-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M2 in MAP kinase JNK1	0.121	335	273	116	427	18	352	8.457E-05	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fi1-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fi1-assembly1.cif.gz_A Crystal structure of scCK2 alpha in complex with ATP	0.131	303	262	91	392	6	308	1.692E-04	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3tku-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3tku-assembly1.cif.gz_A MRCK beta in complex with fasudil	0.122	343	245	48	390	24	303	5.835E-04	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4azt-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4azt-assembly1.cif.gz_A Co-crystal structure of WbdD and kinase inhibitor LY294002.	0.154	276	169	112	387	217	417	6.131E-04	88
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5eyk-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5eyk-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AURORA B IN COMPLEX WITH BI 847325	0.120	298	219	121	418	6	255	2.115E-03	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7qq6-assembly2.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7qq6-assembly2.cif.gz_C GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 1 (dovitinib)	0.160	235	176	119	353	5	215	1.651E-03	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qps-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qps-assembly1.cif.gz_A Crystal structure of Jak3 complexed to N-[3-(6-Phenylamino-pyrazin-2-yl)-3H-benzoimidazol-5-yl]-acrylamide	0.142	262	184	132	393	20	235	4.335E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pe0-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pe0-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-Hydroxy-3-[1-(1H-pyrrol-2-yl)-eth-(Z)-ylidene]-1,3-dihydro-indol-2-one COMPLEX	0.137	246	198	112	357	4	233	2.115E-03	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5k3y-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5k3y-assembly2.cif.gz_B Crystal structure of AuroraB/INCENP in complex with BI 811283	0.116	327	234	92	418	3	268	7.474E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3pwy-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3pwy-assembly1.cif.gz_A Crystal structure of an extender (SPD28345)-modified human PDK1 complex 2	0.122	246	203	112	357	7	238	6.769E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2jbp-assembly8.cif.gz_H	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2jbp-assembly8.cif.gz_H Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization)	0.122	269	202	112	380	12	242	1.651E-03	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6u2h-assembly1.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6u2h-assembly1.cif.gz_D BRAF dimer bound to 14-3-3	0.134	313	229	112	424	5	269	1.226E-03	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pwl-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pwl-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	0.118	317	243	113	429	10	285	1.495E-03	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ivu-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ivu-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor ZD6474	0.138	289	230	112	400	19	286	6.131E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3o0g-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3o0g-assembly1.cif.gz_A Crystal Structure of Cdk5:p25 in complex with an ATP analogue	0.149	264	183	119	382	2	217	1.823E-03	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5feq-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5feq-assembly1.cif.gz_A EGFR KINASE DOMAIN IN COMPLEX WITH A COVALENT AMINOBENZIMIDAZOLE	0.115	304	222	121	424	16	267	2.277E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7u9a-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7u9a-assembly1.cif.gz_A EGFR in complex with a macrocyclic inhibitor	0.115	304	223	121	424	19	271	8.671E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ugx-assembly2.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ugx-assembly2.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Gain-of-Function Mutation	0.115	316	253	113	428	10	296	1.057E-03	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ui0-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ui0-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	0.112	338	260	92	429	6	299	1.651E-03	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4bcf-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4bcf-assembly1.cif.gz_A Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor	0.135	279	236	121	394	14	292	1.226E-03	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4r3r-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4r3r-assembly1.cif.gz_A Crystal structures of EGFR in complex with Mig6	0.118	305	230	121	425	17	278	1.057E-03	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8f1x-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8f1x-assembly1.cif.gz_A EGFR kinase in complex with mobocertinib (TAK-788)	0.112	305	230	121	425	17	276	4.125E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5gtz-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5gtz-assembly1.cif.gz_A Crystal structure of EGFR 696-1022 T790M in complex with JTS-1-39	0.116	305	225	121	425	16	271	5.029E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7zyn-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7zyn-assembly1.cif.gz_A Crystal Structure of EGFR-T790M/C797S in Complex with WZ4002	0.115	304	227	121	424	16	273	5.284E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ogr-assembly3.cif.gz_I	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ogr-assembly3.cif.gz_I crystal structure of P-TEFb complex with AFF4 and Tat	0.131	300	250	121	420	12	300	6.769E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6opi-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6opi-assembly1.cif.gz_A phosphorylated ERK2 with SCH-CPD336	0.140	270	176	112	381	10	215	1.167E-03	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1j91-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1j91-assembly1.cif.gz_A Crystal structure of Z. mays CK2 kinase alpha subunit in complex with the ATP-competitive inhibitor 4,5,6,7-tetrabromobenzotriazole	0.103	312	264	121	432	33	327	4.786E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6a1c-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6a1c-assembly1.cif.gz_A Crystal structure of the CK2a1-go289 complex	0.119	313	260	121	433	38	333	5.284E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xj0-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xj0-assembly2.cif.gz_B Crystal structure of ERK2 in complex with an inhibitor 14K	0.136	268	189	114	381	10	229	4.335E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2xrw-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2xrw-assembly1.cif.gz_A Linear binding motifs for JNK and for calcineurin antagonistically control the nuclear shuttling of NFAT4	0.122	320	256	116	435	24	316	3.221E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6jmf-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6jmf-assembly1.cif.gz_A Crystal structure of human tyrosine-protein kinase Fes/Fps in complex with compound 4	0.142	313	232	113	425	101	371	3.556E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5xzv-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5xzv-assembly1.cif.gz_A Crystal structure of Rad53 1-466 in complex with AMP-PNP	0.146	316	212	79	394	123	371	4.555E-04	87
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3uqg-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3uqg-assembly2.cif.gz_B c-SRC kinase domain in complex with bumpless BKI analog UW1243	0.143	262	184	134	395	22	237	1.354E-03	86
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hzv-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hzv-assembly3.cif.gz_C HUMAN JAK3 IN COMPLEX WITH LASW959 PROTEIN IN COMPLEX WITH LIGAND	0.130	295	222	117	411	9	264	1.823E-03	86
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qps-assembly2.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qps-assembly2.cif.gz_C Crystal structure of Jak3 complexed to N-[3-(6-Phenylamino-pyrazin-2-yl)-3H-benzoimidazol-5-yl]-acrylamide	0.126	303	226	124	426	13	272	1.057E-03	86
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fg9-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fg9-assembly1.cif.gz_A Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-320 in complex with ATP	0.129	329	237	112	440	5	277	2.453E-03	86
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5l6w-assembly1.cif.gz_L	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5l6w-assembly1.cif.gz_L Structure Of the LIMK1-ATPgammaS-CFL1 Complex	0.139	274	224	124	384	16	289	5.029E-04	86
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv2-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv2-assembly1.cif.gz_A Crystal structure of EGFR_wt in complex with covalently bound fragment 4	0.126	304	221	121	424	16	269	5.553E-04	86
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7aei-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7aei-assembly1.cif.gz_A Studies Towards a Reversible EGFR C797S Triple Mutant Inhibitor Series	0.120	303	227	121	423	16	274	6.769E-04	86
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6una-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6una-assembly2.cif.gz_B Crystal structure of inactive p38gamma	0.140	321	248	91	411	5	293	4.125E-04	86
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4h39-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4h39-assembly1.cif.gz_A Crystal Structure of JNK3 in Complex with JIP1 Peptide	0.150	266	173	116	381	18	221	1.167E-03	86
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6tca-assembly3.cif.gz_F	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6tca-assembly3.cif.gz_F Phosphorylated p38 and MAPKAPK2 complex with inhibitor	0.154	283	198	112	394	13	247	7.474E-04	86
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6e9w-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6e9w-assembly1.cif.gz_A Crystal structure of Rock1 with a pyridinylbenzamide based inhibitor	0.132	338	253	62	399	12	304	3.221E-04	86
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4oau-assembly1.cif.gz_C-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4oau-assembly1.cif.gz_C-2 Complete human RNase L in complex with biological activators.	0.122	369	297	13	381	219	557	3.736E-04	86
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8sam-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8sam-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	0.135	270	217	121	390	224	475	1.495E-03	86
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2hz4-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2hz4-assembly2.cif.gz_B Abl kinase domain unligated and in complex with tetrahydrostaurosporine	0.144	294	206	133	426	18	259	2.991E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zc6-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zc6-assembly4.cif.gz_D Crystal structure of JAK3 kinase domain in complex with an indazole substituted pyrrolopyrazine inhibitor	0.126	275	219	124	398	13	264	2.222E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5we8-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5we8-assembly1.cif.gz_A Crystal structure of WNK1 in complex with N-{(3R)-1-[(4-chlorophenyl)methyl]pyrrolidin-3-yl}-2-(3-methoxyphenyl)-N-methylquinoline-4-carboxamide (compound 8)	0.125	296	215	121	416	12	258	1.167E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7sj3-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7sj3-assembly1.cif.gz_A Structure of CDK4-Cyclin D3 bound to abemaciclib	0.125	301	235	120	420	2	270	1.354E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8h75-assembly1.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8h75-assembly1.cif.gz_D FGFR2 in complex with YJ001	0.130	260	218	93	352	1	251	1.735E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6tpf-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6tpf-assembly2.cif.gz_B Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity	0.116	290	232	124	413	15	278	7.853E-04	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uyv-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7uyv-assembly1.cif.gz_A Crystal structure of JAK3 kinase domain in complex with compound 25	0.136	289	224	124	412	13	272	2.846E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4zji-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4zji-assembly4.cif.gz_D PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine	0.135	311	231	112	422	12	279	1.354E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hx8-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hx8-assembly2.cif.gz_B Jak1 complex with 4-[(4-aminocyclohexyl)amino]-3-(1H-benzimidazol-2-yl)-1H-pyridin-2-one	0.112	292	229	132	423	22	280	5.553E-04	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j95-assembly5.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j95-assembly5.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.094	316	246	112	427	9	280	1.571E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5flf-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5flf-assembly3.cif.gz_C DISEASE LINKED MUTATION IN FGFR	0.117	315	236	112	426	10	277	2.453E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6lvl-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6lvl-assembly2.cif.gz_B Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative	0.129	317	240	113	429	10	285	1.571E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5wal-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5wal-assembly1.cif.gz_A Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model	0.118	293	232	133	425	21	284	5.284E-04	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3cly-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3cly-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domains Trapped in Trans-Phosphorylation Reaction	0.113	322	253	112	433	2	287	1.167E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5flf-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5flf-assembly2.cif.gz_B DISEASE LINKED MUTATION IN FGFR	0.122	310	234	124	433	23	290	1.167E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5eg3-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5eg3-assembly1.cif.gz_A Crystal Structure of the Activated FGF Receptor 2 (FGFR2) Kinase Domain in complex with the cSH2 domain of Phospholipase C gamma (PLCgamma)	0.103	342	265	92	433	1	296	1.111E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j96-assembly3.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j96-assembly3.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	0.117	338	260	92	429	6	300	1.915E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4bch-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4bch-assembly1.cif.gz_A Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor	0.141	307	243	114	420	10	293	1.057E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4r3p-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4r3p-assembly1.cif.gz_A Crystal structures of EGFR in complex with Mig6	0.118	305	231	121	425	17	279	3.736E-04	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7b85-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7b85-assembly1.cif.gz_A Crystal Structure of EGFR-WT in Complex with TAK-788	0.113	304	226	121	424	16	271	4.786E-04	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3mvh-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3mvh-assembly1.cif.gz_A Crystal structure of Akt-1-inhibitor complexes	0.144	292	206	133	424	19	260	1.006E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3qkk-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3qkk-assembly1.cif.gz_A Spirochromane Akt Inhibitors	0.126	295	239	121	415	7	280	1.226E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7mtb-assembly1.cif.gz_G	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7mtb-assembly1.cif.gz_G Rhodopsin kinase (GRK1)-S5E/S488E/T489E in complex with rhodopsin and Fab6	0.123	295	248	115	398	22	316	4.786E-04	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1pmv-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1pmv-assembly1.cif.gz_A The structure of JNK3 in complex with a dihydroanthrapyrazole inhibitor	0.152	266	176	116	381	18	226	1.111E-03	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3v3v-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3v3v-assembly1.cif.gz_A Structural and functional analysis of quercetagetin, a natural JNK1 inhibitor	0.131	329	268	116	424	18	346	2.514E-04	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5uzj-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5uzj-assembly1.cif.gz_A Crystal Structure of ROCK1 bound to an aminopyridine inhibitor	0.138	389	244	2	390	5	288	3.065E-04	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4azw-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4azw-assembly1.cif.gz_A Crystal structure of monomeric WbdD.	0.171	263	165	118	380	211	410	7.113E-04	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ezv-assembly2.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ezv-assembly2.cif.gz_C X-ray crystal structure of AMP-activated protein kinase alpha-2/alpha-1 RIM chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) beta-1 gamma-1) co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid)	0.145	293	205	124	416	12	252	6.769E-04	85
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3f9n-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3f9n-assembly1.cif.gz_A Crystal structure of chk1 kinase in complex with inhibitor 38	0.168	193	117	119	311	1	142	1.084E-02	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ate-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ate-assembly1.cif.gz_A SRC kinase bound to covalent inhibitor	0.148	284	195	112	395	6	235	5.982E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7bjr-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7bjr-assembly1.cif.gz_A Crystal structure of CHK1-10pt-mutant complex with compound 18	0.144	270	204	119	388	3	241	2.222E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5wdy-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5wdy-assembly1.cif.gz_A Crystal structure of WNK1 in complex with 1-cyclohexyl-N-({6-fluoro-1-[2-(3-methoxyphenyl)pyridin-4-yl]-1H-indol-3-yl}methyl)methanamine (compound 6)	0.128	237	196	121	357	13	238	2.012E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zfx-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zfx-assembly1.cif.gz_A Crystal structure of EphB1	0.134	304	214	124	427	13	260	1.057E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5uhn-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5uhn-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	0.125	305	220	124	428	17	268	1.057E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6dud-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6dud-assembly1.cif.gz_A JAK3 with cyanamide CP12	0.120	303	226	124	426	13	270	2.709E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6t29-assembly1.cif.gz_AAA	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6t29-assembly1.cif.gz_AAA Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 18 (CS587)	0.143	312	225	114	425	8	271	2.115E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zep-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zep-assembly4.cif.gz_D Crystal Structure of JAK3 Kinase Domain in Complex with a Pyrrolopyrazine-2-phenyl Ether Inhibitor	0.120	303	229	124	426	13	273	2.991E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6db3-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6db3-assembly1.cif.gz_A JAK3 with Cyanamide CP23	0.137	303	224	124	426	13	273	1.354E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8u2o-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8u2o-assembly1.cif.gz_B Crystal Structure of Cdk-related protein kinase 6 (PK6) from Plasmodium falciparum in complex with inhibitor TCMDC-123995	0.155	274	223	121	394	6	270	1.571E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6u5l-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6u5l-assembly1.cif.gz_A Structure of human ULK4 in complex with an inhibitor	0.140	296	221	121	416	6	263	1.354E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6yi8-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6yi8-assembly1.cif.gz_A HUMAN FGFR4 KINASE DOMAIN (447-753) IN COMPLEX WITH ROBLITINIB	0.125	316	232	112	427	10	275	1.111E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5f1z-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5f1z-assembly1.cif.gz_A Structure of TYK2 with inhibitor 16: 3-azanyl-5-[(2~{S})-3-methylbutan-2-yl]-7-[1-methyl-5-(2-oxidanylpropan-2-yl)pyrazol-3-yl]-1~{H}-pyrazolo[4,3-c]pyridin-4-one	0.110	295	228	131	425	23	279	1.167E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6nec-assembly2.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6nec-assembly2.cif.gz_C STRUCTURE OF RET PROTEIN TYROSINE KINASE DOMAIN IN COMPLEX WITH NINTEDANIB	0.144	288	223	113	400	21	281	1.167E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7ju6-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7ju6-assembly1.cif.gz_B Structure of RET protein tyrosine kinase in complex with selpercatinib	0.133	302	247	99	400	3	288	4.786E-04	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7kie-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7kie-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 3	0.115	315	246	113	427	12	290	2.222E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6v6q-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6v6q-assembly1.cif.gz_B Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.118	306	238	124	429	19	289	1.651E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2itw-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2itw-assembly1.cif.gz_A Crystal structure of EGFR kinase domain in complex with AFN941	0.120	287	233	121	407	17	282	1.111E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv7-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv7-assembly1.cif.gz_A Crystal structure of EGFR_TMX in complex with covalently bound fragment 9	0.124	287	223	121	407	17	272	9.111E-04	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv6-assembly1.cif.gz_A Crystal structure of EGFR_TMX in complex with covalently bound fragment 8	0.123	304	226	121	424	17	275	3.556E-04	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6kyr-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6kyr-assembly2.cif.gz_B Crystal structure of DCLK1 mutant (P675L) Autoinhibited Kinase Domain	0.119	310	254	114	423	7	295	4.335E-04	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6lud-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6lud-assembly1.cif.gz_A Crystal Structure of EGFR(L858R/T790M/C797S) in complex with Osimertinib	0.105	304	230	121	424	17	274	7.853E-04	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6s89-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6s89-assembly1.cif.gz_A Crystal Structure of EGFR-T790M/C797S in Complex with Covalent Pyrrolopyrimidine 19g	0.122	315	244	121	435	16	294	4.555E-04	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6npz-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6npz-assembly2.cif.gz_B Crystal structure of Akt1 (aa 123-480) kinase with a bisubstrate	0.128	304	242	112	415	5	283	1.495E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3uvq-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3uvq-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with a Dibenzosuberone Derivative	0.153	279	223	112	390	16	279	5.284E-04	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8wgf-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8wgf-assembly1.cif.gz_A The Crystal Structure of JNK3 from Biortus.	0.143	270	183	112	381	15	229	1.006E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4iz5-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4iz5-assembly2.cif.gz_B Structure of the complex between ERK2 phosphomimetic mutant and PEA-15	0.119	268	194	114	381	11	231	1.354E-03	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5n32-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5n32-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 4-chlorobenzyl carbamimidothioate	0.123	341	257	81	421	13	306	2.642E-04	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qtd-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qtd-assembly1.cif.gz_A Structure of human JNK1 in complex with SCH772984 and the AMPPNP-hydrolysed triphosphate revealing the second type-I binding mode	0.139	281	201	116	396	19	252	7.474E-04	84
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7qwk-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7qwk-assembly3.cif.gz_C GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.149	298	203	112	409	2	240	1.006E-03	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3jvs-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3jvs-assembly1.cif.gz_A Characterization of the Chk1 allosteric inhibitor binding site	0.181	195	114	117	311	4	143	2.063E-02	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vqm-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vqm-assembly1.cif.gz_B Crystal Structure Analysis of human ACK1	0.100	307	230	119	425	8	263	5.982E-03	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3kul-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3kul-assembly2.cif.gz_B Kinase domain of human ephrin type-A receptor 8 (EPHA8)	0.119	306	230	120	425	10	271	2.453E-03	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6v6q-assembly2.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6v6q-assembly2.cif.gz_D Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.137	305	220	124	428	19	274	1.006E-03	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6bql-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6bql-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with TAE-226	0.119	282	237	120	401	8	277	1.495E-03	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4zji-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4zji-assembly1.cif.gz_A PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine	0.139	308	226	112	419	11	273	1.651E-03	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2z60-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2z60-assembly1.cif.gz_A Crystal Structure of the T315I Mutant of Abl kinase bound with PPY-A	0.132	307	218	134	440	29	280	1.651E-03	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ugl-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ugl-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	0.120	305	234	124	428	18	284	1.495E-03	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6nja-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6nja-assembly1.cif.gz_A Structure of WT RET protein tyrosine kinase domain at 1.92A resolution.	0.125	302	248	99	400	7	290	1.111E-03	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4wkq-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4wkq-assembly1.cif.gz_A 1.85 angstrom structure of EGFR kinase domain with gefitinib	0.104	305	228	121	425	19	273	1.354E-03	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j98-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j98-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659Q Mutation.	0.116	332	267	97	428	1	303	1.495E-03	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv8-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv8-assembly1.cif.gz_A Crystal structure of EGFR_TMX in complex with covalently bound fragment 10	0.119	304	226	121	424	17	274	6.442E-04	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j96-assembly3.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j96-assembly3.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	0.108	306	249	124	429	24	303	2.222E-03	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5vib-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5vib-assembly1.cif.gz_A Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based inhibitors	0.112	303	260	99	401	2	295	4.555E-04	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xj0-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xj0-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an inhibitor 14K	0.139	302	245	124	425	18	302	9.111E-04	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7q4a-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7q4a-assembly1.cif.gz_B Toxoplasma gondii PRP4K kinase domain (L715F) bound to altiratinib	0.146	298	217	91	388	10	264	1.006E-03	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4jrn-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4jrn-assembly1.cif.gz_A ROP18 kinase domain in complex with AMP-PNP and sucrose	0.126	345	292	63	407	10	344	6.442E-04	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7jij-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7jij-assembly1.cif.gz_A ATP-bound AMP-activated protein kinase	0.127	282	240	117	392	5	286	5.029E-04	83
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3jvr-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3jvr-assembly1.cif.gz_A Characterization of the Chk1 allosteric inhibitor binding site	0.143	272	202	117	388	4	240	3.142E-03	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hzv-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hzv-assembly4.cif.gz_D HUMAN JAK3 IN COMPLEX WITH LASW959 PROTEIN IN COMPLEX WITH LIGAND	0.113	275	216	124	398	12	256	3.470E-03	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ccf-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ccf-assembly1.cif.gz_A Crystal Structure of the Human CAMKK1A in complex with Hesperadin	0.133	283	221	119	401	4	259	2.012E-03	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7kp6-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7kp6-assembly2.cif.gz_B Structure of Ack1 kinase in complex with a selective inhibitor	0.125	297	213	124	420	14	257	2.991E-03	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6t28-assembly1.cif.gz_AAA	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6t28-assembly1.cif.gz_AAA Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 19 (CS640)	0.146	312	222	114	425	8	268	3.646E-03	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j97-assembly6.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j97-assembly6.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	0.129	317	238	112	428	9	282	4.907E-03	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7kia-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7kia-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	0.120	316	242	113	428	11	286	1.354E-03	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5flf-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5flf-assembly1.cif.gz_A DISEASE LINKED MUTATION IN FGFR	0.131	301	235	124	424	23	293	1.651E-03	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vjn-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vjn-assembly1.cif.gz_A-2 Crystal structure of the mutated EGFR kinase domain (G719S/T790M) in complex with AMPPNP.	0.113	304	228	121	424	16	273	6.769E-04	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5jeb-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5jeb-assembly1.cif.gz_A Crystal structure of EGFR tyrosine kinase domain with novel inhibitor of active state of HER2	0.112	287	230	121	407	14	273	9.111E-04	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv1-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv1-assembly1.cif.gz_A Crystal structure of EGFR_DMX in complex with covalently bound fragment 1	0.113	304	228	121	424	17	274	8.252E-04	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2gs6-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2gs6-assembly1.cif.gz_A-2 Crystal Structure of the active EGFR kinase domain in complex with an ATP analog-peptide conjugate	0.113	304	229	121	424	20	278	9.111E-04	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r7i-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r7i-assembly3.cif.gz_C Crystal structure of catalytic subunit of protein kinase CK2	0.124	291	240	134	424	46	320	7.113E-04	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ekd-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ekd-assembly1.cif.gz_A Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor	0.140	314	248	116	429	17	305	1.651E-03	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ccy-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ccy-assembly1.cif.gz_A Crystal structure of Akt1 in complex with a selective inhibitor	0.138	303	218	121	423	10	263	1.226E-03	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4u79-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4u79-assembly1.cif.gz_A Crystal structure of human JNK3 in complex with a benzenesulfonamide inhibitor.	0.156	266	170	116	381	19	220	1.823E-03	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3pze-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3pze-assembly1.cif.gz_A JNK1 in complex with inhibitor	0.133	311	251	116	426	18	308	8.252E-04	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3v6r-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3v6r-assembly2.cif.gz_B Discovery of potent and selective covalent inhibitors of JNK	0.144	285	200	112	396	14	248	1.111E-03	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vum-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vum-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M7 in MAP kinase JNK1	0.116	324	275	116	427	18	341	4.786E-04	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8elc-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8elc-assembly1.cif.gz_A Human JNK2 bound to covalent inhibitor YL2056	0.140	266	184	116	381	16	230	2.012E-03	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6e4t-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6e4t-assembly1.cif.gz_A Structure of AMPK bound to activator	0.144	266	204	124	389	12	250	1.423E-03	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8sam-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8sam-assembly1.cif.gz_A Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	0.133	300	219	110	409	217	470	1.495E-03	82
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4zjj-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4zjj-assembly2.cif.gz_B PAK1 in complex with (S)-N-(tert-butyl)-3-((2-chloro-5-ethyl-8-fluoro-dibenzodiazepin-11-yl)amino)pyrrolidine-1-carboxamide	0.134	339	237	81	419	1	275	1.226E-03	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7ozy-assembly1.cif.gz_AAA	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7ozy-assembly1.cif.gz_AAA FGFR2 kinase domain (residues 461-763) in complex with 38.	0.124	311	236	113	423	11	280	3.646E-03	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3my0-assembly21.cif.gz_U	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3my0-assembly21.cif.gz_U Crystal structure of the ACVRL1 (ALK1) kinase domain bound to LDN-193189	0.108	304	244	121	424	9	283	1.111E-03	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7nzn-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7nzn-assembly1.cif.gz_A Structure of RET kinase domain bound to inhibitor JB-48	0.137	277	223	124	400	27	285	1.423E-03	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5flf-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5flf-assembly4.cif.gz_D DISEASE LINKED MUTATION IN FGFR	0.134	305	233	124	428	18	287	1.823E-03	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7nwk-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7nwk-assembly1.cif.gz_A Crystal structure of CDK9-Cyclin T1 bound by compound 6	0.135	271	229	124	394	17	282	2.453E-03	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5em7-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5em7-assembly1.cif.gz_A EGFR kinase domain mutant "TMLR" with pyridone compound 13: 4-[(2-methoxyphenyl)amino]-~{N}-[4-(4-methylpiperazin-1-yl)phenyl]-2-oxidanylidene-1~{H}-pyridine-3-carboxamide	0.100	304	220	121	424	17	261	7.113E-04	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7si1-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7si1-assembly1.cif.gz_A Crystal structure of apo EGFR kinase domain	0.128	287	224	121	407	19	276	8.671E-04	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2gs2-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2gs2-assembly1.cif.gz_A-2 Crystal Structure of the active EGFR kinase domain	0.121	287	230	121	407	17	279	9.111E-04	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hib-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hib-assembly1.cif.gz_A EGFR kinase domain mutant "TMLR" with a pyrazolopyrimidine inhibitor	0.113	304	227	121	424	17	273	6.769E-04	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1cm8-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1cm8-assembly2.cif.gz_B PHOSPHORYLATED MAP KINASE P38-GAMMA	0.140	287	229	134	420	28	294	4.335E-04	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qp2-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qp2-assembly2.cif.gz_B Crystal Structure of ERKs in complex with 5-chlorobenzo[d]oxazol-2-amine	0.116	322	283	112	433	8	328	1.289E-03	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6emh-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6emh-assembly4.cif.gz_D Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor	0.142	270	173	112	381	13	215	3.302E-03	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8enj-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8enj-assembly1.cif.gz_A Design, synthesis, biological evaluation, and X-ray crystallography of diarylpyrazole derivatives possessing terminal arylsulfonamide moieties as anti-proliferative agents targeting c-Jun N-terminal kinase (JNK)	0.137	320	261	116	435	18	321	1.057E-03	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ke0-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ke0-assembly1.cif.gz_A Discovery of 1-1H-Pyrazolo 4,3-c pyridine-6-yl urea Inhibitors of Extracellular Signal Regulated Kinase ERK for the Treatment of Cancers	0.120	302	252	124	425	12	298	7.853E-04	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1rdq-assembly1.cif.gz_E	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1rdq-assembly1.cif.gz_E Hydrolysis of ATP in the crystal of Y204A mutant of cAMP-dependent protein kinase	0.138	303	250	99	401	11	301	2.062E-04	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fv1-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fv1-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK4	0.140	314	255	112	425	9	305	7.113E-04	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3elj-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3elj-assembly1.cif.gz_A Jnk1 complexed with a bis-anilino-pyrrolopyrimidine inhibitor.	0.126	327	252	116	404	18	344	1.111E-03	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2fys-assembly2.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2fys-assembly2.cif.gz_A Crystal structure of Erk2 complex with KIM peptide derived from MKP3	0.118	335	281	114	433	12	346	7.113E-04	81
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7bjx-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7bjx-assembly2.cif.gz_B Crystal structure of CHK1-10pt-mutant complex with compound 26	0.179	174	102	133	306	12	136	9.816E-03	80
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3pa5-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3pa5-assembly1.cif.gz_A X-ray crystal structure of compound 1 bound to human CHK1 kinase domain	0.162	195	117	117	311	3	143	1.611E-02	80
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2qi8-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2qi8-assembly1.cif.gz_A Crystal structure of drug resistant SRC kinase domain	0.105	319	214	119	437	9	248	1.651E-03	80
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5jrs-assembly2.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5jrs-assembly2.cif.gz_A CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH 4-[2-FLUORO-3-(4-OXO -3,4-DIHYDROQUINAZOLIN-3-YL)PHENYL]-7-(2-HYDROXYPROPAN-2-Y L)-9H-CARBAZOLE-1-CARBOXAMIDE	0.129	307	215	120	426	9	256	3.646E-03	80
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fsz-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fsz-assembly1.cif.gz_A Crystal Structure of the CHK1	0.135	272	208	117	388	3	244	3.831E-03	80
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5bvw-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5bvw-assembly1.cif.gz_A Fragment-based discovery of potent and selective DDR1/2 inhibitors	0.129	244	194	112	355	2	225	1.735E-03	80
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ei4-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ei4-assembly1.cif.gz_A JAK1 kinase (JH1 domain) in complex with compound 20	0.115	300	233	124	423	27	290	8.671E-04	80
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ug2-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ug2-assembly1.cif.gz_A-2 Crystal structure of the mutated EGFR kinase domain (G719S/T790M) in complex with gefitinib	0.111	304	225	121	424	16	269	1.111E-03	80
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1na7-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1na7-assembly1.cif.gz_A Crystal structure of the catalytic subunit of human protein kinase CK2	0.116	325	279	96	420	1	317	1.354E-03	80
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4cxa-assembly1.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4cxa-assembly1.cif.gz_C Crystal structure of the human CDK12-cyclin K complex bound to AMPPNP	0.166	262	186	121	382	10	233	2.335E-03	80
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ntj-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ntj-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compound RKp032	0.142	335	257	81	415	15	315	2.167E-04	80
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4kke-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4kke-assembly1.cif.gz_A The crystal structure of AMP-bound JNK3	0.141	281	201	116	396	18	252	1.495E-03	80
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3npc-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3npc-assembly1.cif.gz_A Crystal structure of JNK2 complexed with BIRB796	0.147	266	183	116	381	18	232	9.574E-04	80
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6o8b-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6o8b-assembly1.cif.gz_B Crystal structure of STING CTD in complex with TBK1	0.149	191	137	118	308	7	168	1.139E-02	80
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2zv2-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2zv2-assembly1.cif.gz_A Crystal structure of human calcium/calmodulin-dependent protein kinase kinase 2, beta, CaMKK2 kinase domain in complex with STO-609	0.120	176	114	133	308	17	146	1.084E-02	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fsu-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fsu-assembly1.cif.gz_A Crystal Structure of the CHK1	0.135	273	221	117	389	2	257	5.418E-03	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vvg-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vvg-assembly1.cif.gz_B Structure of the Cydia pomonella Granulovirus kinase, PK-1	0.102	287	229	114	400	8	263	6.940E-03	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6cd6-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6cd6-assembly4.cif.gz_D Crystal Structure of the Human CAMKK1A in complex with GSK650394	0.130	298	220	121	418	6	259	2.222E-03	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zep-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zep-assembly2.cif.gz_B Crystal Structure of JAK3 Kinase Domain in Complex with a Pyrrolopyrazine-2-phenyl Ether Inhibitor	0.137	277	212	133	409	19	265	3.142E-03	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2py3-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2py3-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation Responsible for Pfeiffer Syndrome	0.125	318	237	112	429	9	280	3.302E-03	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4zjv-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4zjv-assembly1.cif.gz_A crystal structure of EGFR kinase domain in complex with Mitogen-inducible gene 6 protein	0.124	287	231	121	407	10	274	2.991E-03	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7vdp-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7vdp-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 1	0.126	297	239	124	420	4	278	4.025E-03	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ui0-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ui0-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	0.106	338	266	92	429	5	303	3.142E-03	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3cqu-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3cqu-assembly1.cif.gz_A Crystal Structure of Akt-1 complexed with substrate peptide and inhibitor	0.111	304	248	112	415	1	280	4.907E-03	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3e88-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3e88-assembly2.cif.gz_B Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors	0.120	295	239	121	415	7	279	2.991E-03	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r7i-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r7i-assembly1.cif.gz_A Crystal structure of catalytic subunit of protein kinase CK2	0.122	291	241	134	424	47	321	8.252E-04	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6eq9-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6eq9-assembly2.cif.gz_B Crystal structure of JNK3 in complex with AMP-PCP	0.150	281	189	116	396	16	238	2.453E-03	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4x21-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4x21-assembly2.cif.gz_B The MAP kinase JNK3 as target for halogen bonding	0.162	281	187	116	396	16	239	9.574E-04	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3l9m-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3l9m-assembly2.cif.gz_B Crystal structure of PKAB3 (pka triple mutant V123A, L173M, Q181K) with compound 18	0.114	317	260	99	415	7	300	3.736E-04	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yhj-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yhj-assembly1.cif.gz_B Structure and Function of the Hypertension Variant A486V of G Protein-coupled Receptor Kinase 4 (GRK4)	0.130	430	335	6	435	52	437	2.167E-04	79
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1h4l-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1h4l-assembly2.cif.gz_B Structure and regulation of the CDK5-p25(nck5a) complex	0.133	177	114	133	309	12	144	2.168E-02	78
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6v6q-assembly2.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6v6q-assembly2.cif.gz_C Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.118	316	240	112	427	3	275	2.991E-03	78
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5fed-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5fed-assembly1.cif.gz_A EGFR kinase domain in complex with a covalent aminobenzimidazole inhibitor.	0.112	304	221	121	424	16	265	1.495E-03	78
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3mtl-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3mtl-assembly1.cif.gz_A Crystal structure of the PCTAIRE1 kinase in complex with Indirubin E804	0.146	264	167	119	382	2	197	2.991E-03	78
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vjo-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vjo-assembly1.cif.gz_A-2 Crystal structure of the wild-type EGFR kinase domain in complex with AMPPNP.	0.120	287	229	121	407	17	277	1.226E-03	78
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ec9-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ec9-assembly1.cif.gz_A Crystal structure of full-length cdk9 in complex with cyclin t	0.167	269	218	133	395	22	290	2.453E-03	78
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3j4q-assembly1.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3j4q-assembly1.cif.gz_D Pseudo-atomic model of the AKAP18-PKA complex in a bent conformation derived from electron microscopy	0.128	317	255	99	415	7	300	3.926E-04	78
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7ksk-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7ksk-assembly1.cif.gz_A Thiophenyl-Pyrazolourea Derivatives as Potent, Brian Penetrant, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors	0.141	281	195	116	396	17	244	2.335E-03	78
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5bui-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5bui-assembly1.cif.gz_A ERK2 complexed with 2-pyridiyl tetrahydroazaindazole	0.109	302	246	124	425	19	295	2.115E-03	78
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ptg-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ptg-assembly1.cif.gz_A Design and Synthesis of a Novel, Orally Efficacious Tri-substituted Thiophene Based JNK Inhibitor	0.122	311	248	116	426	17	300	5.835E-04	78
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3llt-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3llt-assembly1.cif.gz_A Crystal structure of PF14_0431, kinase domain.	0.119	321	265	117	418	14	334	1.651E-03	78
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5f0a-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5f0a-assembly1.cif.gz_A CRYSTAL STRUCTURE OF PVX_084705 WITH BOUND 1-tert-butyl-3-(3-chlorophenoxy)-1H-pyrazolo[3,4-d]pyrimidin-4-amine INHIBITOR	0.127	291	243	110	400	518	796	1.423E-03	78
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6bqp-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6bqp-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with Crenolanib	0.118	282	225	120	401	7	262	1.139E-02	77
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4gh2-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4gh2-assembly1.cif.gz_A Crystal Structure of the CHK1	0.144	272	205	117	388	3	242	7.293E-03	77
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j97-assembly5.cif.gz_C-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j97-assembly5.cif.gz_C-2 Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	0.111	313	247	112	424	3	281	4.907E-03	77
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7run-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7run-assembly2.cif.gz_B Crystal structure of phosphorylated RET tyrosine kinase domain complexed with a pyrrolo[2,3-d]pyrimidine inhibitor.	0.136	314	236	112	425	14	287	1.915E-03	77
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7nj0-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7nj0-assembly1.cif.gz_B CryoEM structure of the human Separase-Cdk1-cyclin B1-Cks1 complex	0.147	264	184	119	382	2	218	1.057E-03	77
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ug1-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3ug1-assembly1.cif.gz_A-2 Crystal structure of the mutated EGFR kinase domain (G719S/T790M) in the apo form	0.123	287	225	121	407	16	273	1.735E-03	77
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv9-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv9-assembly1.cif.gz_A Crystal structure of EGFR_TMX in complex with covalently bound fragment 12	0.114	305	229	121	425	17	275	1.226E-03	77
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2b1p-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2b1p-assembly1.cif.gz_A inhibitor complex of JNK3	0.143	266	169	116	381	17	214	5.693E-03	77
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1ywr-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1ywr-assembly1.cif.gz_A Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone Inhibitor	0.143	282	233	112	393	16	288	8.671E-04	77
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4eym-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4eym-assembly1.cif.gz_A MAPK13 complex with inhibitor	0.122	308	239	112	419	20	292	8.671E-04	77
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yno-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yno-assembly1.cif.gz_A Crystal structure of MAPK13 at INACTIVE FORM	0.116	319	278	112	427	20	338	9.574E-04	77
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2jd5-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2jd5-assembly1.cif.gz_A Sky1p bound to Npl3p-derived substrate peptide	0.148	260	199	123	382	18	252	4.230E-03	77
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5my8-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5my8-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with SPHINX31	0.127	238	207	94	331	1	238	7.663E-03	77
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5jrs-assembly3.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5jrs-assembly3.cif.gz_B CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH 4-[2-FLUORO-3-(4-OXO -3,4-DIHYDROQUINAZOLIN-3-YL)PHENYL]-7-(2-HYDROXYPROPAN-2-Y L)-9H-CARBAZOLE-1-CARBOXAMIDE	0.131	307	200	120	426	9	239	5.418E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7kx8-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7kx8-assembly2.cif.gz_B Crystal structure of DCLK1-Cter in complex with FMF-03-055-1	0.146	264	193	132	395	20	246	2.846E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4hzr-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4hzr-assembly2.cif.gz_B Crystal structure of Ack1 kinase domain	0.132	267	205	132	398	18	254	2.991E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4mne-assembly2.cif.gz_F	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4mne-assembly2.cif.gz_F Crystal structure of the BRAF:MEK1 complex	0.134	294	206	134	427	17	255	7.663E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7suf-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7suf-assembly1.cif.gz_A Structure of CHK1 10-pt. mutant complex with LRRK2 inhibitor 06	0.149	277	210	117	393	3	250	1.031E-02	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1u4d-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1u4d-assembly2.cif.gz_B Structure of the ACK1 Kinase Domain bound to Debromohymenialdisine	0.111	305	222	121	425	10	260	9.342E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r0u-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2r0u-assembly1.cif.gz_A Crystal Structure of Chek1 in Complex with Inhibitor 54	0.188	190	113	117	306	4	143	5.555E-02	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4mne-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4mne-assembly1.cif.gz_B Crystal structure of the BRAF:MEK1 complex	0.139	292	214	133	424	18	267	5.693E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1jow-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1jow-assembly1.cif.gz_B Crystal structure of a complex of human CDK6 and a viral cyclin	0.123	250	182	132	381	9	216	5.418E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zep-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zep-assembly3.cif.gz_C Crystal Structure of JAK3 Kinase Domain in Complex with a Pyrrolopyrazine-2-phenyl Ether Inhibitor	0.141	277	218	133	409	19	273	4.670E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2psq-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2psq-assembly1.cif.gz_B Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domain	0.127	306	231	124	429	19	284	5.693E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6elr-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6elr-assembly1.cif.gz_A Human jak1 kinase domain in complex with compound 7	0.115	291	227	133	423	32	288	4.786E-04	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv5-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hv5-assembly1.cif.gz_A Crystal structure of EGFR_DMX in complex with compound 7	0.133	287	226	121	407	17	278	2.453E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7t4i-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7t4i-assembly1.cif.gz_A Crystal Structure of wild type EGFR in complex with TAK-788	0.123	287	232	121	407	16	281	3.646E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yr8-assembly1.cif.gz_E	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yr8-assembly1.cif.gz_E Crystal structure of JNK in complex with a regulator protein	0.149	281	186	116	396	18	237	1.915E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5m56-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5m56-assembly2.cif.gz_B Monoclinic complex structure of human protein kinase CK2 catalytic subunit (isoform CK2alpha') with the inhibitor 4'-carboxy-6,8-chloro-flavonol (FLC21)	0.111	335	290	92	426	1	327	1.167E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3w55-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3w55-assembly1.cif.gz_A The structure of ERK2 in complex with FR148083	0.128	328	259	111	408	5	332	3.646E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qp1-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qp1-assembly2.cif.gz_B Crystal structure of ERK2 in complex with N-cyclohexyl-9H-purin-6-amine	0.127	270	193	112	381	8	229	4.444E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2gmx-assembly3.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2gmx-assembly3.cif.gz_B Selective Aminopyridine-Based C-Jun N-terminal Kinase inhibitors with cellular activity	0.134	304	246	112	415	14	298	7.853E-04	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6b1u-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6b1u-assembly1.cif.gz_A Structure of full-length human AMPK (a2b1g1) in complex with a small molecule activator SC4	0.143	352	274	124	475	13	333	4.335E-04	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4uw0-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4uw0-assembly1.cif.gz_A Low resolution structure of WbdD with C-terminal bundle ordered to residue 505	0.165	337	235	118	454	218	500	1.226E-03	76
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2h6d-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2h6d-assembly1.cif.gz_A Protein Kinase Domain of the Human 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK alpha-2 chain)	0.149	269	193	120	388	8	235	8.890E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7qwk-assembly7.cif.gz_G	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7qwk-assembly7.cif.gz_G GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.156	263	189	119	381	5	229	1.823E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8fe9-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8fe9-assembly1.cif.gz_A Crystal structure of Ack1 kinase K161Q mutant in complex with the selective inhibitor (R)-9b	0.135	284	228	119	402	8	272	6.605E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zep-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3zep-assembly1.cif.gz_A Crystal Structure of JAK3 Kinase Domain in Complex with a Pyrrolopyrazine-2-phenyl Ether Inhibitor	0.135	289	224	124	412	13	272	1.139E-02	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vpm-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vpm-assembly1.cif.gz_B TPX2 residues 7-20 fused to Aurora A residues 116-389 with C290 disulfide bonded to compound 8-34, and in complex with AMP-PNP	0.117	283	220	121	403	25	274	3.646E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4b8m-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4b8m-assembly2.cif.gz_B Aurora B kinase in complex with VX-680	0.121	334	232	92	425	4	268	4.670E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3dak-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3dak-assembly3.cif.gz_C Crystal Structure of Domain-Swapped OSR1 kinase domain	0.136	272	222	124	395	15	272	5.693E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6i82-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6i82-assembly1.cif.gz_A Crystal structure of partially phosphorylated RET V804M tyrosine kinase domain complexed with PDD00018412	0.135	277	215	124	400	29	278	1.289E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j97-assembly5.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j97-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	0.142	276	234	112	387	9	282	9.342E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ivs-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ivs-assembly1.cif.gz_A Crystal structure of non-phosphorylated RET tyrosine kinase domain	0.131	288	237	113	400	8	281	4.025E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7run-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7run-assembly1.cif.gz_A Crystal structure of phosphorylated RET tyrosine kinase domain complexed with a pyrrolo[2,3-d]pyrimidine inhibitor.	0.129	319	237	112	430	15	287	2.578E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4i23-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4i23-assembly1.cif.gz_A Crystal structure of the wild-type EGFR kinase domain in complex with dacomitinib (soaked)	0.116	293	218	133	425	28	275	1.057E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7aem-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7aem-assembly1.cif.gz_A Studies Towards a Reversible EGFR C797S Triple Mutant Inhibitor Series	0.114	304	229	121	424	18	277	6.131E-04	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ots-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6ots-assembly1.cif.gz_A Rat ERK2 E320K	0.115	311	264	113	411	12	322	2.578E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ekn-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ekn-assembly1.cif.gz_A Crystal structure of MAPK13 complex with inhibitor	0.107	316	279	112	427	20	332	1.354E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5nhf-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5nhf-assembly1.cif.gz_A Human Erk2 with an Erk1/2 inhibitor	0.130	308	252	118	425	14	304	1.651E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3e7o-assembly2.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3e7o-assembly2.cif.gz_A Crystal Structure of JNK2	0.137	281	204	116	396	16	252	4.444E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6emh-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6emh-assembly2.cif.gz_B Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor	0.141	276	190	116	391	17	238	4.230E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5lcj-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5lcj-assembly1.cif.gz_A In-Gel Activity-Based Protein Profiling of a Clickable Covalent Erk 1/2 Inhibitor	0.115	308	257	118	425	15	305	1.111E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hd7-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5hd7-assembly1.cif.gz_A Dissecting Therapeutic Resistance to ERK Inhibition Rat Mutant SCH772984 in complex with (3R)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]piperazin-1-yl}ethyl)-N-[3-(pyridin-4-yl)-2H-indazol-5-yl]pyrrolidine-3-carboxamide	0.112	312	261	114	425	11	305	3.470E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vud-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vud-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1	0.103	335	276	119	427	18	352	1.289E-03	75
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2xey-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2xey-assembly1.cif.gz_A Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors	0.138	270	214	120	389	3	251	6.605E-03	74
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1u46-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1u46-assembly2.cif.gz_B Crystal Structure of the Unphosphorylated Kinase Domain of the Tyrosine Kinase ACK1	0.107	293	211	133	425	19	255	4.230E-03	74
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vqm-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6vqm-assembly1.cif.gz_A-2 Crystal Structure Analysis of human ACK1	0.105	300	224	121	420	10	260	6.286E-03	74
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6gr9-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6gr9-assembly1.cif.gz_A Human AURKC INCENP complex bound to VX-680	0.150	283	215	121	403	7	260	4.230E-03	74
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pz5-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pz5-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549T Mutation Responsible for Pfeiffer Syndrome	0.118	298	226	132	429	22	278	5.418E-03	74
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pzp-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pzp-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible for Crouzon Syndrome	0.135	298	221	132	429	22	278	3.302E-03	74
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8ho6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8ho6-assembly1.cif.gz_A ScRIPK WT	0.146	301	222	123	423	20	280	3.831E-03	74
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6lvl-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6lvl-assembly1.cif.gz_A Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative	0.113	318	246	112	429	9	286	3.831E-03	74
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5yf9-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5yf9-assembly2.cif.gz_B Crystal structure of CK2a2 form-2	0.109	322	283	92	413	1	319	2.222E-03	74
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1q99-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1q99-assembly1.cif.gz_A Crystal structure of the Saccharomyces cerevisiae SR protein kinsae, Sky1p, complexed with the non-hydrolyzable ATP analogue, AMP-PNP	0.148	260	200	123	382	19	254	4.670E-03	74
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fto-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fto-assembly1.cif.gz_A Crystal Structure of the CHK1	0.148	272	198	117	388	3	235	6.940E-03	73
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6s75-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6s75-assembly2.cif.gz_B Crystal structure of Nek7 bound to compound 51	0.116	306	218	121	426	15	262	4.444E-03	73
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pvy-assembly1.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pvy-assembly1.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome.	0.119	297	228	132	428	23	282	2.453E-03	73
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6i82-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6i82-assembly1.cif.gz_B Crystal structure of partially phosphorylated RET V804M tyrosine kinase domain complexed with PDD00018412	0.123	313	244	113	425	7	285	2.453E-03	73
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6yum-assembly2.cif.gz_GGG	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6yum-assembly2.cif.gz_GGG CK2 alpha bound to unclosed Macrocycle	0.119	296	244	134	429	47	324	2.335E-03	73
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3s4q-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3s4q-assembly1.cif.gz_A P38 alpha kinase complexed with a pyrazolo-triazine based inhibitor	0.154	286	223	116	401	19	283	3.302E-03	73
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6g9a-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6g9a-assembly1.cif.gz_A Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2	0.126	308	253	118	425	18	308	4.670E-03	73
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3v6s-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3v6s-assembly1.cif.gz_A Discovery of potent and selective covalent inhibitors of JNK	0.138	315	257	112	426	14	312	4.670E-03	73
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6byr-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6byr-assembly1.cif.gz_A Structures of the PKA RI alpha holoenzyme with the FLHCC driver J-PKAc alpha or native PKAc alpha	0.119	393	308	23	415	17	367	2.917E-04	73
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4hzr-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4hzr-assembly1.cif.gz_A Crystal structure of Ack1 kinase domain	0.107	288	210	133	420	20	255	3.302E-03	72
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1unh-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1unh-assembly2.cif.gz_B Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin.	0.114	289	230	132	420	11	271	6.286E-03	72
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2q0b-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2q0b-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565A Mutation Responsible for Pfeiffer Syndrome	0.126	317	235	113	429	10	279	8.052E-03	72
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1ung-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1ung-assembly1.cif.gz_A Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin.	0.124	251	176	132	382	12	213	1.321E-02	72
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2x2k-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2x2k-assembly1.cif.gz_A Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	0.137	277	224	124	400	26	286	2.578E-03	72
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7egb-assembly1.cif.gz_8	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7egb-assembly1.cif.gz_8 TFIID-based holo PIC on SCP promoter	0.131	263	183	119	381	1	212	5.982E-03	72
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xoy-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xoy-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an inhibitor	0.122	312	251	114	425	11	297	4.025E-03	72
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2exc-assembly1.cif.gz_X	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2exc-assembly1.cif.gz_X Inhibitor complex of JNK3	0.121	317	274	116	428	18	334	2.991E-03	72
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4eyj-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4eyj-assembly1.cif.gz_A MAPK13 Complex with inhibitor	0.109	313	277	116	427	22	334	1.057E-03	72
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5nhp-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5nhp-assembly1.cif.gz_A Human Erk2 with an Erk1/2 inhibitor	0.139	305	246	114	418	11	297	3.646E-03	72
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3o50-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3o50-assembly1.cif.gz_A Crystal structure of benzamide 9 bound to AuroraA	0.118	305	207	121	425	8	243	8.461E-03	71
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3eqr-assembly2.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3eqr-assembly2.cif.gz_A Crystal Structure of Ack1 with compound T74	0.125	302	221	124	425	14	266	3.831E-03	71
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pvy-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pvy-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome.	0.130	297	224	132	428	28	285	4.670E-03	71
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fuy-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fuy-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK2	0.122	312	253	114	425	8	296	3.302E-03	71
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5u6i-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5u6i-assembly1.cif.gz_A Discovery of MLi-2, an Orally Available and Selective LRRK2 Inhibitor that Reduces Brain Kinase Activity	0.134	293	240	133	425	20	297	4.907E-03	71
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4s30-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4s30-assembly1.cif.gz_A ERK2 intrinsically active mutant (I84A)	0.130	334	260	112	411	8	341	2.335E-03	71
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4s34-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4s34-assembly1.cif.gz_A ERK2 (I84A) in complex with AMP-PNP	0.129	314	258	112	425	9	305	3.831E-03	71
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2gmx-assembly3.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2gmx-assembly3.cif.gz_A Selective Aminopyridine-Based C-Jun N-terminal Kinase inhibitors with cellular activity	0.133	264	184	118	381	19	231	4.025E-03	71
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ezv-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ezv-assembly1.cif.gz_A X-ray crystal structure of AMP-activated protein kinase alpha-2/alpha-1 RIM chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) beta-1 gamma-1) co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid)	0.156	293	203	124	416	13	253	8.671E-04	71
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3fdn-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3fdn-assembly1.cif.gz_A Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity	0.125	292	207	121	412	8	244	4.907E-03	70
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5o2b-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5o2b-assembly1.cif.gz_A Crystal structure of WNK3 kinase domain in a diphosphorylated state and in a complex with the inhibitor PP-121	0.158	316	213	104	419	2	255	9.342E-03	70
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ft9-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ft9-assembly1.cif.gz_A Crystal Structure of the CHK1	0.139	272	207	117	388	4	244	1.257E-02	70
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7vdr-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7vdr-assembly2.cif.gz_B The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 13	0.130	286	225	135	420	10	269	8.461E-03	70
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pzr-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pzr-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K641R Mutation Responsible for Pfeiffer Syndrome	0.121	298	226	132	429	22	279	6.605E-03	70
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2x2m-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2x2m-assembly1.cif.gz_B Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	0.127	287	224	112	398	17	274	4.025E-03	70
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pvy-assembly1.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pvy-assembly1.cif.gz_C Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome.	0.111	297	228	132	428	28	284	6.940E-03	70
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2x2m-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2x2m-assembly1.cif.gz_A Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	0.151	269	211	132	400	34	283	2.453E-03	70
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7zks-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7zks-assembly1.cif.gz_A SRPK1 IN COMPLEX WITH INHIBITOR	0.146	328	264	110	419	6	333	8.052E-03	70
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1q97-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1q97-assembly1.cif.gz_A The structure of the Saccharomyces cerevisiae SR protein kinase, Sky1p, with bound ATP	0.158	260	196	123	382	18	251	1.321E-02	70
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6o8b-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6o8b-assembly1.cif.gz_A Crystal structure of STING CTD in complex with TBK1	0.129	267	210	112	378	1	242	1.321E-02	70
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4rvl-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4rvl-assembly1.cif.gz_A CHK1 kinase domain with diazacarbazole compound 7: 3-(2-hydroxyphenyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile	0.143	272	202	117	388	3	239	1.197E-02	69
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1u54-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1u54-assembly2.cif.gz_B Crystal Structures of the Phosphorylated and Unphosphorylated Kinase Domains of the CDC42-associated Tyrosine Kinase ACK1 bound to AMP-PCP	0.113	278	220	121	398	10	258	1.692E-02	69
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ftt-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ftt-assembly1.cif.gz_A Crystal Structure of the CHK1	0.137	272	205	117	388	3	240	1.692E-02	69
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ftc-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ftc-assembly1.cif.gz_A Crystal Structure of the CHK1	0.143	272	203	117	388	4	241	1.139E-02	69
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7vdq-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7vdq-assembly2.cif.gz_B The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 7	0.128	248	173	135	382	8	206	1.031E-02	69
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2euf-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2euf-assembly1.cif.gz_B X-ray structure of human CDK6-Vcyclin in complex with the inhibitor PD0332991	0.122	302	238	119	420	2	273	2.222E-03	69
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pvy-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pvy-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome.	0.125	296	230	132	427	23	286	5.156E-03	69
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1pmu-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1pmu-assembly1.cif.gz_A The crystal structure of JNK3 in complex with a phenantroline inhibitor	0.123	324	273	116	427	18	341	2.222E-03	69
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ux9-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ux9-assembly4.cif.gz_D Crystal structure of JNK1 bound to a MKK7 docking motif	0.155	263	186	134	396	26	246	4.907E-03	69
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vwa-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3vwa-assembly1.cif.gz_A Crystal structure of Cex1p	0.111	397	281	120	516	14	330	2.453E-03	69
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ftm-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ftm-assembly1.cif.gz_A Crystal Structure of the CHK1	0.150	272	199	117	388	3	237	1.197E-02	68
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hmt-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8hmt-assembly2.cif.gz_B The complex of ACK1 with the inhibitor 2-142	0.136	288	211	133	420	20	264	6.940E-03	68
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2py3-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2py3-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation Responsible for Pfeiffer Syndrome	0.124	315	239	113	427	10	283	9.816E-03	68
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3nyx-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3nyx-assembly1.cif.gz_A Non-phosphorylated TYK2 JH1 domain with Quinoline-Thiadiazole-Thiophene Inhibitor	0.114	294	231	132	425	23	284	2.709E-03	68
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4bcj-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4bcj-assembly1.cif.gz_A Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor	0.142	267	223	134	394	28	294	5.418E-03	68
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ywm-assembly1.cif.gz_X	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ywm-assembly1.cif.gz_X Crystal structure of CK2a2 form-1	0.121	281	237	133	413	43	313	5.156E-03	68
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hkn-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6hkn-assembly1.cif.gz_A Crystal structure of Compound 35 with ERK5	0.139	330	266	124	433	3	332	2.709E-03	68
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6emh-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6emh-assembly3.cif.gz_C Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor	0.131	285	196	112	396	13	238	8.052E-03	68
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5clr-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5clr-assembly1.cif.gz_A Crystal structure of LegK4_APO Kinase	0.141	301	256	132	430	75	375	1.226E-03	68
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ym8-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ym8-assembly1.cif.gz_A Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors	0.141	256	200	134	389	11	244	9.342E-03	67
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ftr-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4ftr-assembly1.cif.gz_A Crystal Structure of the CHK1	0.130	272	207	117	388	3	241	1.459E-02	67
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3tni-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3tni-assembly1.cif.gz_A structure of CDK9/cyclin T F241L	0.140	261	224	134	394	23	283	3.831E-03	67
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fv4-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fv4-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK7	0.110	289	245	112	400	11	286	6.940E-03	67
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5eko-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5eko-assembly1.cif.gz_A Crystal structure of MAPK13 complex with inhibitor	0.114	316	276	116	427	22	337	3.646E-03	67
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4w4y-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4w4y-assembly1.cif.gz_A JNK2/3 in complex with 3-(4-{[(4-methylphenyl)carbamoyl]amino}-1H-pyrazol-1-yl)-N-(2-methylpyridin-4-yl)benzamide	0.153	266	180	116	381	18	231	1.197E-02	67
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pz5-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pz5-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549T Mutation Responsible for Pfeiffer Syndrome	0.130	298	223	132	429	22	278	8.461E-03	66
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1how-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1how-assembly1.cif.gz_A THE X-RAY CRYSTAL STRUCTURE OF SKY1P, AN SR PROTEIN KINASE IN YEAST	0.136	304	260	121	424	15	316	9.816E-03	66
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3dzo-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3dzo-assembly1.cif.gz_A Crystal structure of a rhoptry kinase from toxoplasma gondii	0.091	300	250	125	424	70	345	3.302E-03	66
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ym5-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2ym5-assembly1.cif.gz_A Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors	0.134	256	204	134	389	11	246	1.869E-02	65
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7xbr-assembly2.cif.gz_F	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7xbr-assembly2.cif.gz_F Crystal structure of phosphorylated AtMKK5	0.137	285	203	134	418	14	249	9.342E-03	65
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pzp-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pzp-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible for Crouzon Syndrome	0.124	296	227	132	427	22	281	1.257E-02	65
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yr8-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yr8-assembly3.cif.gz_C Crystal structure of JNK in complex with a regulator protein	0.138	288	193	109	396	3	227	9.816E-03	65
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5t5t-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5t5t-assembly1.cif.gz_A AMPK bound to allosteric activator	0.134	290	223	124	413	12	269	2.335E-03	65
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fst-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4fst-assembly1.cif.gz_A Crystal Structure of the CHK1	0.135	272	203	117	388	3	238	1.964E-02	64
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j97-assembly6.cif.gz_D-3	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4j97-assembly6.cif.gz_D-3 Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	0.095	293	233	132	424	25	283	1.257E-02	64
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qp6-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qp6-assembly1.cif.gz_A Crystal Structure of ERK2 in complex with 5H-pyrrolo[2,3-b]pyrazine	0.121	308	246	118	425	14	294	8.461E-03	64
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qp1-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qp1-assembly1.cif.gz_A Crystal structure of ERK2 in complex with N-cyclohexyl-9H-purin-6-amine	0.132	278	205	124	401	18	254	8.052E-03	64
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2w1z-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2w1z-assembly2.cif.gz_B ROP2 from Toxoplasma gondii: A virulence factor with a protein- kinase fold and no enzymatic activity.	0.123	356	308	63	418	4	355	9.816E-03	64
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2q0b-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2q0b-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565A Mutation Responsible for Pfeiffer Syndrome	0.126	298	225	132	429	23	280	1.964E-02	63
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3g9l-assembly1.cif.gz_X	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3g9l-assembly1.cif.gz_X JNK3 bound to (Z)-1-((6-fluoro-4H-benzo[d][1,3]dioxin-8-yl)methyl)-3-(hydroxyimino)-4-styrylindolin-2-one	0.150	266	169	116	381	17	216	1.459E-02	63
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qp2-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qp2-assembly1.cif.gz_A Crystal Structure of ERKs in complex with 5-chlorobenzo[d]oxazol-2-amine	0.126	315	251	124	411	18	332	6.286E-03	63
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ckw-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5ckw-assembly1.cif.gz_B Crystal structure of LegK4_AMPPNP Kinase	0.123	393	297	71	410	7	399	1.006E-03	63
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1u46-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1u46-assembly1.cif.gz_A Crystal Structure of the Unphosphorylated Kinase Domain of the Tyrosine Kinase ACK1	0.111	293	209	133	425	19	254	2.278E-02	62
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yr8-assembly2.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4yr8-assembly2.cif.gz_A Crystal structure of JNK in complex with a regulator protein	0.140	281	188	116	396	17	236	1.611E-02	62
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qpa-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qpa-assembly1.cif.gz_A Crystal Structure of ERK2 in complex with 7-(1-benzyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H-pyrrolo[2,3-b]pyrazine	0.127	264	185	118	381	11	223	1.321E-02	62
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4zzo-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4zzo-assembly1.cif.gz_A Human ERK2 in complex with an irreversible inhibitor	0.126	308	253	118	425	15	305	1.031E-02	62
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7w5o-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7w5o-assembly2.cif.gz_B Crystal structure of ERK2 with an allosteric inhibitor	0.127	327	251	124	411	18	344	6.940E-03	62
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4lv8-assembly2.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4lv8-assembly2.cif.gz_A Murine IRGa6 bound to Toxoplasma ROP5C, a pseudokinase GDI	0.093	259	213	49	307	1	236	5.287E-02	62
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2vwi-assembly1.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2vwi-assembly1.cif.gz_D Structure of the OSR1 kinase, a hypertension drug target	0.135	293	235	121	413	12	284	1.869E-02	61
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xrl-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4xrl-assembly1.cif.gz_A Crystal structure at room temperature of Erk2 in complex with an inhibitor	0.138	249	175	133	381	28	231	6.940E-03	61
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5owq-assembly3.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5owq-assembly3.cif.gz_B Human STK10 bound to dovitinib	0.118	285	216	121	405	5	250	4.337E-02	59
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1ung-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1ung-assembly2.cif.gz_B Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin.	0.157	241	169	201	401	28	268	2.515E-02	59
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6rfp-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6rfp-assembly1.cif.gz_A ERK2 MAP kinase with mutations at Helix-G	0.123	310	253	116	425	11	299	9.816E-03	59
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2g2i-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2g2i-assembly2.cif.gz_B A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain	0.135	225	188	133	357	20	237	3.557E-02	58
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6m7z-assembly5.cif.gz_E	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6m7z-assembly5.cif.gz_E A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	0.106	317	231	79	395	2	260	2.643E-02	58
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3byv-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3byv-assembly1.cif.gz_A Crystal structure of Toxoplasma gondii specific rhoptry antigen kinase domain	0.103	307	251	125	431	62	342	9.342E-03	58
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6m7z-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6m7z-assembly3.cif.gz_C A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	0.124	172	132	227	398	105	256	3.928E-02	57
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4feu-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4feu-assembly3.cif.gz_C Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.080	272	213	132	403	29	261	6.445E-02	56
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3o0g-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3o0g-assembly2.cif.gz_B Crystal Structure of Cdk5:p25 in complex with an ATP analogue	0.119	147	123	236	382	53	193	5.837E-02	56
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5clr-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5clr-assembly1.cif.gz_B Crystal structure of LegK4_APO Kinase	0.121	266	177	201	402	54	319	5.418E-03	56
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fxv-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6fxv-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	0.121	293	243	133	425	25	302	1.197E-02	56
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4im0-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4im0-assembly1.cif.gz_A-2 Structure of Tank-Binding Kinase 1	0.117	282	241	117	398	5	278	2.063E-02	56
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4feu-assembly6.cif.gz_F	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4feu-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.089	272	210	132	403	13	244	8.256E-02	55
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6m7z-assembly4.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6m7z-assembly4.cif.gz_D A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	0.111	271	180	140	410	52	254	3.928E-02	55
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7ukz-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7ukz-assembly3.cif.gz_C CDK11 in complex with small molecule inhibitor OTS964	0.126	251	174	131	381	12	211	3.222E-02	54
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6m7z-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6m7z-assembly1.cif.gz_A A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	0.105	319	221	85	403	9	256	3.386E-02	53
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6m7z-assembly6.cif.gz_F	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6m7z-assembly6.cif.gz_F A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	0.108	325	225	79	403	1	253	3.557E-02	52
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qpa-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4qpa-assembly2.cif.gz_B Crystal Structure of ERK2 in complex with 7-(1-benzyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H-pyrrolo[2,3-b]pyrazine	0.115	293	242	133	425	27	301	2.515E-02	52
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pk9-assembly3.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2pk9-assembly3.cif.gz_C Structure of the Pho85-Pho80 CDK-cyclin Complex of the Phosphate-responsive Signal Transduction Pathway	0.119	174	144	208	381	24	188	9.115E-02	50
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4im2-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4im2-assembly1.cif.gz_A Structure of Tank-Binding Kinase 1	0.115	282	242	117	398	5	278	2.013E-01	44
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3lcb-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3lcb-assembly1.cif.gz_A The crystal structure of isocitrate dehydrogenase kinase/phosphatase in complex with its substrate, isocitrate dehydrogenase, from Escherichia coli.	0.106	452	272	2	306	13	464	2.454E-01	33
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6k5l-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6k5l-assembly1.cif.gz_B The crystal structure of isocitrate dehydrogenase kinase/phosphatase wtih two Mn2+ from E. coli	0.085	461	278	2	306	13	473	1.168E-01	33
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3eps-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3eps-assembly1.cif.gz_A The crystal structure of isocitrate dehydrogenase kinase/phosphatase from E. coli	0.079	466	280	2	306	15	480	1.735E-01	32
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4p69-assembly1.cif.gz_A-2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	4p69-assembly1.cif.gz_A-2 Acek (D477A) ICDH complex	0.096	452	275	2	306	13	464	2.115E-01	30
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8bmq-assembly1.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8bmq-assembly1.cif.gz_D Cryo-EM structure of the folate-specific ECF transporter complex in MSP2N2 lipid nanodiscs bound to AMP-PNP	0.119	237	199	314	540	20	256	5.421E-01	29
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3eps-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3eps-assembly2.cif.gz_B The crystal structure of isocitrate dehydrogenase kinase/phosphatase from E. coli	0.089	466	277	2	306	15	480	2.454E-01	29
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6k5l-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	6k5l-assembly1.cif.gz_A The crystal structure of isocitrate dehydrogenase kinase/phosphatase wtih two Mn2+ from E. coli	0.095	466	275	2	306	16	481	2.847E-01	29
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8at3-assembly1.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8at3-assembly1.cif.gz_C Structure of the augmin holocomplex in open conformation	0.139	241	206	309	548	65	305	5.985E-01	27
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3lcb-assembly2.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3lcb-assembly2.cif.gz_B The crystal structure of isocitrate dehydrogenase kinase/phosphatase in complex with its substrate, isocitrate dehydrogenase, from Escherichia coli.	0.087	541	357	2	393	12	552	6.944E-01	25
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7o3x-assembly1.cif.gz_B	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7o3x-assembly1.cif.gz_B Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity	0.179	190	151	314	498	25	214	4.790E+00	21
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5c5b-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5c5b-assembly1.cif.gz_A Crystal Structure of Human APPL BAR-PH Heterodimer	0.103	319	207	153	471	14	245	1.779E+00	21
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5c5b-assembly2.cif.gz_C	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	5c5b-assembly2.cif.gz_C Crystal Structure of Human APPL BAR-PH Heterodimer	0.100	319	209	153	471	14	246	1.870E+00	21
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7o3w-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7o3w-assembly1.cif.gz_A Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity	0.146	190	161	313	502	24	212	3.223E+00	20
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3lc6-assembly2.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	3lc6-assembly2.cif.gz_A The alternative conformation structure of isocitrate dehydrogenase kinase/phosphatase from E. Coli	0.076	471	277	6	306	4	474	1.258E+00	20
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7o3x-assembly1.cif.gz_E	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7o3x-assembly1.cif.gz_E Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity	0.169	190	153	314	498	25	214	6.448E+00	19
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7o3x-assembly1.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7o3x-assembly1.cif.gz_D Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity	0.182	187	147	318	498	28	214	9.119E+00	17
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2j7a-assembly3.cif.gz_N	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	2j7a-assembly3.cif.gz_N Crystal structure of cytochrome c nitrite reductase NrfHA complex from Desulfovibrio vulgaris	0.137	120	92	311	418	333	452	4.339E+00	17
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7o3z-assembly1.cif.gz_D	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	7o3z-assembly1.cif.gz_D Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity	0.156	190	155	314	498	25	214	9.582E+00	16
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8otz-assembly1.cif.gz_F2	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8otz-assembly1.cif.gz_F2 48-nm repeat of the native axonemal doublet microtubule from bovine sperm	0.084	393	290	156	548	59	376	6.448E+00	16
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8to0-assembly1.cif.gz_Gd	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	8to0-assembly1.cif.gz_Gd 48-nm repeating structure of doublets from mouse sperm flagella	0.129	395	248	154	548	17	302	5.840E+00	15
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1t6p-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1t6p-assembly1.cif.gz_A Crystal Structure of Phenylalanine Ammonia Lyase from Rhodosporidium toruloides	0.100	535	464	5	539	62	577	7.860E+00	11
DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1y2m-assembly1.cif.gz_A	DESULFOASV1_2116_2-polyprenylphenol_6-hydroxylase	1y2m-assembly1.cif.gz_A Crystal structure of phenylalanine ammonia-lyase from yeast Rhododporidium toruloides	0.116	364	260	50	413	371	665	7.860E+00	11
